Stromal-derived	B-protein
factor	I-protein
1	I-protein
and	O
thrombopoietin	B-protein
regulate	O
distinct	O
aspects	O
of	O
human	O
megakaryopoiesis	O
.	O

The	O
role	O
of	O
the	O
chemokine	B-protein
binding	O
stromal-derived	B-protein
factor	I-protein
1	I-protein
(	O
SDF-1	B-protein
)	O
in	O
normal	O
human	O
megakaryopoiesis	O
at	O
the	O
cellular	O
and	O
molecular	O
levels	O
and	O
its	O
comparison	O
with	O
that	O
of	O
thrombopoietin	B-protein
(	O
TPO	B-protein
)	O
have	O
not	O
been	O
determined	O
.	O

In	O
this	O
study	O
it	O
was	O
found	O
that	O
SDF-1	B-protein
,	O
unlike	O
TPO	B-protein
,	O
does	O
not	O
stimulate	O
alpha	O
(	O
IIb	O
)	O
beta	O
(	O
3	O
)	O
(	O
+	O
)	O
cell	O
proliferation	O
or	O
differentiation	O
or	O
have	O
an	O
antiapoptotic	O
effect	O
.	O

However	O
,	O
it	O
does	O
induce	O
chemotaxis	O
,	O
trans-Matrigel	O
migration	O
,	O
and	O
secretion	O
of	O
matrix	O
metalloproteinase	B-protein
9	I-protein
(	O
MMP-9	B-protein
)	O
and	O
vascular	B-protein
endothelial	I-protein
growth	I-protein
factor	I-protein
(	O
VEGF	B-protein
)	O
by	O
these	O
cells	O
,	O
and	O
both	O
SDF-1	B-protein
and	O
TPO	B-protein
increase	O
the	O
adhesion	O
of	O
alpha	B-cell_type
(	I-cell_type
IIb	I-cell_type
)	I-cell_type
beta	I-cell_type
(	I-cell_type
3	I-cell_type
)	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
to	O
fibrinogen	B-protein
and	O
vitronectin	B-protein
.	O

Investigating	O
the	O
intracellular	O
signaling	O
pathways	O
induced	O
by	O
SDF-1	B-protein
and	O
TPO	B-protein
revealed	O
some	O
overlapping	O
patterns	O
of	O
protein	O
phosphorylation/activation	O
(	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
[	I-protein
MAPK	I-protein
]	I-protein
p42/44	I-protein
,	O
MAPK	B-protein
p38	I-protein
,	O
and	O
AKT	B-protein
[	I-protein
protein	I-protein
kinase	I-protein
B	I-protein
]	I-protein
)	O
and	O
some	O
that	O
were	O
distinct	O
for	O
TPO	B-protein
(	O
eg	O
,	O
JAK-STAT	B-protein
)	O
and	O
for	O
SDF-1	B-protein
(	O
eg	O
,	O
NF-kappa	B-protein
B	I-protein
)	O
.	O

It	O
was	O
also	O
found	O
that	O
though	O
inhibition	O
of	O
phosphatidyl-inositol	B-protein
3-kinase	I-protein
(	O
PI-3K	B-protein
)	O
by	O
LY294002	O
in	O
alpha	B-cell_type
(	I-cell_type
IIb	I-cell_type
)	I-cell_type
beta	I-cell_type
(	I-cell_type
3	I-cell_type
)	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
cells	I-cell_type
induced	O
apoptosis	O
and	O
inhibited	O
chemotaxis	O
adhesion	O
and	O
the	O
secretion	O
of	O
MMP-9	B-protein
and	O
VEGF	B-protein
,	O
the	O
inhibition	O
of	O
MAPK	B-protein
p42/44	I-protein
(	O
by	O
the	O
MEK	O
inhibitor	O
U0126	O
)	O
had	O
no	O
effect	O
on	O
the	O
survival	O
,	O
proliferation	O
,	O
and	O
migration	O
of	O
these	O
cells	O
.	O

Hence	O
,	O
it	O
is	O
suggested	O
that	O
the	O
proliferative	O
effect	O
of	O
TPO	B-protein
is	O
more	O
related	O
to	O
activation	O
of	O
the	O
JAK-STAT	O
pathway	O
(	O
unique	O
to	O
TPO	B-protein
)	O
,	O
and	O
the	O
PI-3K-AKT	O
axis	O
is	O
differentially	O
involved	O
in	O
TPO-	O
and	O
SDF-1-dependent	O
signaling	O
.	O

Accordingly	O
,	O
PI-3K	B-protein
is	O
involved	O
in	O
TPO	B-protein
-mediated	O
inhibition	O
of	O
apoptosis	O
,	O
TPO-	O
and	O
SDF-1-regulated	O
adhesion	O
to	O
fibrinogen	B-protein
and	O
vitronectin	B-protein
,	O
and	O
SDF-1	B-protein
-mediated	O
migration	O
.	O

This	O
study	O
expands	O
the	O
understanding	O
of	O
the	O
role	O
of	O
SDF-1	B-protein
and	O
TPO	B-protein
in	O
normal	O
human	O
megakaryopoiesis	O
and	O
indicates	O
the	O
molecular	O
basis	O
of	O
the	O
observed	O
differences	O
in	O
cellular	O
responses	O
.	O

(	O
Blood.	O
2000	O
;	O
96	O
:	O
4142-4151	O
)	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
Stromal-derived	NULL
factor	NULL
1	NULL
and	NULL
thrombopoietin	NULL
regulate	NULL
distinct	NULL
aspects	NULL
of	NULL
human	NULL
megakaryopoiesis	NULL
Marcin	NULL
Majka	NULL
,	NULL
Anna	NULL
Janowska-Wieczorek	NULL
,	NULL
Janina	NULL
Ratajczak	NULL
,	NULL
M.	NULL
Anna	NULL
Kowalska	NULL
,	NULL
Gaston	NULL
Vilaire	NULL
,	NULL
Zhixing	NULL
K.	NULL
Pan	NULL
,	NULL
Marek	NULL
Honczarenko	NULL
,	NULL
Leah	NULL
A.	NULL
Marquez	NULL
,	NULL
Mortimer	NULL
Poncz	NULL
,	NULL
and	NULL
Mariusz	NULL
Z.	NULL
Ratajczak	NULL
The	NULL
role	NULL
of	NULL
the	NULL
chemokine	NULL
binding	NULL
stromal-derived	NULL
factor	NULL
1	NULL
(	NULL
SDF-1	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
megakaryopoiesis	NULL
at	NULL
the	NULL
cellular	NULL
and	NULL
molecular	NULL
levels	NULL
and	NULL
its	NULL
comparison	NULL
with	NULL
that	NULL
of	NULL
thrombopoietin	NULL
(	NULL
TPO	NULL
)	NULL
have	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

In	NULL
this	NULL
study	NULL
it	NULL
was	NULL
found	NULL
that	NULL
SDF-1	NULL
,	NULL
unlike	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
stimulate	NULL
oj	NULL
,	NULL
,6	NULL
;	NULL
+*	NULL
cell	NULL
proliferation	NULL
or	NULL
differentiation	NULL
or	NULL
have	NULL
an	NULL
antiapoptotic	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
it	NULL
does	NULL
induce	NULL
chemotaxis	NULL
,	NULL
trans-Matrige	NULL
!	NULL

migration	NULL
,	NULL
and	NULL
secretion	NULL
of	NULL
matrix	NULL
metalloproteinase	NULL
9	NULL
(	NULL
MMP-9	NULL
)	NULL
and	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
(	NULL
VEGF	NULL
)	NULL
by	NULL
these	NULL
cells	NULL
,	NULL
and	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
increase	NULL
the	NULL
adhesion	NULL
of	NULL
«	NULL
jpfBzs*	NULL
cells	NULL
to	NULL
fibrinogen	NULL
and	NULL
vitronectin	NULL
.	NULL

Investigating	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
in	NULL
duced	NULL
by	NULL
SDF-1	NULL
and	NULL
TPO	NULL
revealed	NULL
some	NULL
overlapping	NULL
patterns	NULL
of	NULL
protein	NULL
phosphor-ylation/activation	NULL
(	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
[	NULL
MAPK	NULL
]	NULL
p42/44	NULL
,	NULL
MAPK	NULL
p38	NULL
,	NULL
and	NULL
AKT	NULL
[	NULL
protein	NULL
kinase	NULL
BJ	NULL
)	NULL
and	NULL
some	NULL
that	NULL
were	NULL
distinct	NULL
for	NULL
TPO	NULL
(	NULL
eg	NULL
,	NULL
JAK-STAT	NULL
)	NULL
and	NULL
for	NULL
SDF-1	NULL
(	NULL
eg	NULL
,	NULL
NF-kB	NULL
)	NULL
.	NULL

It	NULL
was	NULL
also	NULL
found	NULL
that	NULL
though	NULL
inhibition	NULL
of	NULL
phosphati-dyl-inositol	NULL
3-kinase	NULL
(	NULL
PI-3K	NULL
)	NULL
by	NULL
LY294002	NULL
in	NULL
cells	NULL
induced	NULL
apoptosis	NULL
and	NULL
inhibited	NULL
chemotaxis	NULL
adhesion	NULL
and	NULL
the	NULL
secretion	NULL
of	NULL
MMP-9	NULL
and	NULL
VEGF	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
MAPK	NULL
p42/44	NULL
(	NULL
by	NULL
the	NULL
MEK	NULL
inhibitor	NULL
UO126	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
migration	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
is	NULL
suggested	NULL
that	NULL
the	NULL
proliferative	NULL
effect	NULL
of	NULL
TPO	NULL
is	NULL
more	NULL
related	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
(	NULL
unique	NULL
to	NULL
TPO	NULL
)	NULL
,	NULL
and	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
is	NULL
differentially	NULL
involved	NULL
in	NULL
TPO-	NULL
and	NULL
SDF-1-dependent	NULL
signaling	NULL
.	NULL

Accordingly	NULL
,	NULL
PI-3K	NULL
is	NULL
involved	NULL
in	NULL
TPO-mediated	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
TPO-	NULL
and	NULL
SDF-1-regulated	NULL
adhesion	NULL
to	NULL
fibrinogen	NULL
and	NULL
vitronectin	NULL
,	NULL
and	NULL
SDF-1-mediated	NULL
migration	NULL
.	NULL

This	NULL
study	NULL
expands	NULL
the	NULL
understanding	NULL
of	NULL
the	NULL
role	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
in	NULL
normal	NULL
human	NULL
megakaryopoiesis	NULL
and	NULL
indicates	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
cellular	NULL
responses	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2000	NULL
;	NULL
96	NULL
:	NULL
4142-4151	NULL
)	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
The	NULL
immunoglobulin	NULL
superfamily	NULL
cytokine	NULL
receptor	NULL
c-mpl	NULL
binds	NULL
thrombopoietin	NULL
(	NULL
TPO	NULL
)	NULL
,	NULL
and	NULL
the	NULL
7-transmembrane	NULL
G-protein-coupled	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
binds	NULL
stromal-derived	NULL
factor	NULL
1	NULL
(	NULL
SDF-1	NULL
)	NULL
.	NULL
'	NULL

8	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
genes	NULL
for	NULL
TPO	NULL
or	NULL
c-mpl	NULL
results	NULL
in	NULL
thrombocytopenia	NULL
,	NULL
and	NULL
animals	NULL
defective	NULL
in	NULL
either	NULL
SDF-1	NULL
or	NULL
CXCR4	NULL
have	NULL
a	NULL
deficit	NULL
in	NULL
colony-forming	NULL
units-megakaryocyte	NULL
(	NULL
CFU-MK	NULL
)	NULL
in	NULL
the	NULL
adult	NULL
marrow	NULL
.	NULL
``	NULL

Both	NULL
receptors	NULL
are	NULL
present	NULL
in	NULL
high	NULL
concentrations	NULL
on	NULL
the	NULL
surfaces	NULL
of	NULL
developing	NULL
megakaryocytes	NULL
,	NULL
``	NULL
but	NULL
though	NULL
the	NULL
role	NULL
of	NULL
c-mpl	NULL
during	NULL
megakaryopoiesis	NULL
has	NULL
been	NULL
established	NULL
,	NULL
that	NULL
of	NULL
CXCR4	NULL
is	NULL
less	NULL
clear	NULL
.	NULL

SDF-1	NULL
stimulates	NULL
chemotaxis	NULL
of	NULL
early	NULL
megakaryocytic	NULL
progenitors	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
megakaryocytic	NULL
(	NULL
ay	NULL
,	NULL
fB3	NULL
*	NULL
)	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
potentially	NULL
in	NULL
the	NULL
release	NULL
of	NULL
platelets	NULL
.	NULL

!	NULL
``	NULL

A	NULL
recent	NULL
study	NULL
using	NULL
a	NULL
murine	NULL
model	NULL
has	NULL
also	NULL
indicated	NULL
that	NULL
SDF-1	NULL
acts	NULL
together	NULL
with	NULL
TPO	NULL
in	NULL
promoting	NULL
CFU-MK	NULL
proliferation	NULL
,	NULL
``	NULL
which	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
studies	NULL
by	NULL
our	NULL
group	NULL
and	NULL
others	NULL
showing	NULL
that	NULL
SDF-1	NULL
does	NULL
not	NULL
effect	NULL
megakaryocytic	NULL
precursor	NULL
proliferation	NULL
.	NULL

!	NULL
``	NULL

We	NULL
have	NULL
previously	NULL
described	NULL
a	NULL
method	NULL
using	NULL
a	NULL
chemically	NULL
defined	NULL
artificial	NULL
serum	NULL
for	NULL
ex	NULL
vivo	NULL
expansion	NULL
of	NULL
normal	NULL
human	NULL
ap	NULL
,	NULL
f3*	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
which	NULL
were	NULL
shown	NULL
by	NULL
immunophenotypical	NULL
and	NULL
morphologic	NULL
criteria	NULL
to	NULL
be	NULL
megakaryoblasts	NULL
'	NULL
``	NULL
*	NULL
?	NULL

2	NULL
and	NULL
,	NULL
hence	NULL
,	NULL
are	NULL
a	NULL
good	NULL
model	NULL
for	NULL
studying	NULL
various	NULL
aspects	NULL
of	NULL
megakaryopoiesis	NULL
and	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Although	NULL
some	NULL
SDF-1	NULL
and	NULL
TPO	NULL
signaling	NULL
pathways	NULL
have	NULL
been	NULL
investigated	NULL
in	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
,	NULL
platelets	NULL
,	NULL
and	NULL
murine	NULL
megakaryocytes	NULL
,	NULL
``	NULL
``	NULL
``	NULL
``	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
in	NULL
normal	NULL
human	NULL
oy	NULL
,	NULL
B	NULL
;	NULL
*	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
elucidated	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
which	NULL
of	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
are	NULL
critical	NULL
for	NULL
regulating	NULL
various	NULL
aspects	NULL
of	NULL
human	NULL
megakaryopoiesis	NULL
(	NULL
proliferation	NULL
,	NULL
differen-tiation	NULL
,	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
and	NULL
so	NULL
on	NULL
)	NULL
'	NULL
;	NULL
moreover	NULL
,	NULL
data	NULL
derived	NULL
from	NULL
cell	NULL
lines	NULL
can	NULL
not	NULL
always	NULL
be	NULL
reliably	NULL
extrapolated	NULL
.	NULL
``	NULL

The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
extend	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
megakaryopoiesis	NULL
by	NULL
investigating	NULL
the	NULL
biologic	NULL
responses	NULL
of	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
to	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
or	NULL
TPO	NULL
and	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
involved	NULL
(	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
[	NULL
MAPK	NULL
]	NULL
p42/44	NULL
,	NULL
p38	NULL
,	NULL
JNK	NULL
,	NULL
AKT	NULL
[	NULL
protein	NULL
kinase	NULL
BJ	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
STAT-1	NULL
,	NULL
STAT-3	NULL
,	NULL
STAT-5	NULL
,	NULL
and	NULL
STAT-6	NULL
)	NULL
.	NULL

Similarities	NULL
and	NULL
discrepancies	NULL
observed	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
particular	NULL
pathways	NULL
were	NULL
related	NULL
to	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
on	NULL
cell	NULL
activation	NULL
,	NULL
adhesion	NULL
,	NULL
proliferation	NULL
,	NULL
apoptosis	NULL
,	NULL
and	NULL
secretion	NULL
of	NULL
matrix	NULL
metalloproteinase-9	NULL
(	NULL
MMP-9	NULL
)	NULL
and	NULL
vascular	NULL
endothelial	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Alberta	NULL
,	NULL
and	NULL
Canadian	NULL
Blood	NULL
Services	NULL
,	NULL
Edmonton	NULL
,	NULL
Alberta	NULL
,	NULL
Canada	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Molecular	NULL
and	NULL
Experimental	NULL
Medicine	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
March	NULL
10	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
August	NULL
21	NULL
,	NULL
2000	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
RO1	NULL
HL61796-01	NULL
(	NULL
M.Z.R	NULL
.	NULL

,	NULL
M.A.K	NULL
.	NULL

,	NULL
and	NULL
M.P	NULL
.	NULL
)	NULL

,	NULL
Leukemia	NULL
and	NULL
Lymphoma	NULL
Society	NULL
grant	NULL
64907-00	NULL
(	NULL
M.Z.R	NULL
.	NULL
)	NULL

,	NULL
and	NULL
Canadian	NULL
Blood	NULL
Services	NULL
Research	NULL
and	NULL
Development	NULL
grant	NULL
XE	NULL
0004	NULL
4142	NULL
(	NULL
AJ.W..	NULL
Reprints	NULL
:	NULL
Mariusz	NULL
Z.	NULL
Ratajczak	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
,	NULL
405A	NULL
Stellar	NULL
Chance	NULL
Labs	NULL
,	NULL
422	NULL
Curie	NULL
Blvd	NULL
,	NULL
Philadelphia	NULL
PA	NULL
19104	NULL
;	NULL
e-mail	NULL
:	NULL
mariusz	NULL
@	NULL
mail.med.upenn.edu	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
growth	NULL
factor	NULL
(	NULL
VEGF	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
significance	NULL
of	NULL
our	NULL
observations	NULL
,	NULL
we	NULL
blocked	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI-3K	NULL
)	NULL
activity	NULL
and	NULL
MAPK	NULL
p42/44	NULL
pathway	NULL
with	NULL
the	NULL
specific	NULL
inhibitors	NULL
LY294002	NULL
and	NULL
UO126	NULL
,	NULL
respectively	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
SDF-1	NULL
and	NULL
TPO	NULL
activate	NULL
human	NULL
megakaryoblastic	NULL
a	NULL
,	NULL
B3	NULL
;	NULL
*	NULL
cells	NULL
by	NULL
overlapping	NULL
(	NULL
MAPKp42/44	NULL
,	NULL
p38	NULL
,	NULL
AKT	NULL
)	NULL
,	NULL
but	NULL
distinct	NULL
,	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
(	NULL
JAK-STAT	NULL
for	NULL
TPO	NULL
and	NULL
NF-kB	NULL
for	NULL
SDF-1	NULL
)	NULL
.	NULL

The	NULL
result	NULL
of	NULL
these	NULL
differences	NULL
in	NULL
intracellular	NULL
signaling	NULL
appears	NULL
to	NULL
be	NULL
that	NULL
SDF-1	NULL
increases	NULL
the	NULL
interaction	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
their	NULL
microenvironment	NULL
but	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
their	NULL
proliferation	NULL
,	NULL
differentiation	NULL
and	NULL
survival	NULL
,	NULL
whereas	NULL
TPO	NULL
has	NULL
the	NULL
opposite	NULL
role	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
proliferative	NULL
effect	NULL
of	NULL
TPO	NULL
is	NULL
more	NULL
related	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
unique	NULL
to	NULL
TPO	NULL
and	NULL
that	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
,	NULL
which	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
biology	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
,	NULL
is	NULL
differentially	NULL
involved	NULL
in	NULL
TPO	NULL
and	NULL
SDF-1-dependent	NULL
signaling	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Human	NULL
CD34	NULL
+	NULL
cells	NULL
,	NULL
megakaryoblasts	NULL
,	NULL
and	NULL
platelets	NULL
Light-density	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
(	NULL
BM	NULL
MNCs	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
consenting	NULL
healthy	NULL
donors	NULL
,	NULL
depleted	NULL
of	NULL
adherent	NULL
cells	NULL
and	NULL
T	NULL
lympho-cytes	NULL
(	NULL
A~T-	NULL
MNCs	NULL
)	NULL
,	NULL
and	NULL
enriched	NULL
for	NULL
CD34*	NULL
cells	NULL
by	NULL
immunoaffinity	NULL
selection	NULL
with	NULL
MiniMACS	NULL
paramagnetic	NULL
beads	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
.	NULL

``	NULL
``	NULL
``	NULL
%	NULL
203	NULL
%	NULL
3	NULL
``	NULL
The	NULL
purity	NULL
of	NULL
isolated	NULL
BM	NULL
CD34*	NULL
cells	NULL
was	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
.	NULL

BM	NULL
CD34+*	NULL
cells	NULL
were	NULL
expanded	NULL
in	NULL
a	NULL
serum-free	NULL
liquid	NULL
system	NULL
,	NULL
and	NULL
growth	NULL
of	NULL
CFU-MK	NULL
was	NULL
stimulated	NULL
with	NULL
recombinant	NULL
human	NULL
(	NULL
rh	NULL
)	NULL
TPO	NULL
(	NULL
50	NULL
ng/mL	NULL
)	NULL
and	NULL
rhIL-3	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
(	NULL
both	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
as	NULL
described	NULL
.	NULL
'	NULL

''	NULL
2	NULL
>	NULL
``	NULL
``	NULL
After	NULL
incubation	NULL
for	NULL
11	NULL
days	NULL
at	NULL
37°C	NULL
,	NULL
approximately	NULL
85	NULL
%	NULL
of	NULL
the	NULL
expanded	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
megakaryocytic-specific	NULL
marker	NULL
onsB3*	NULL
,	NULL
``	NULL
**	NULL
>	NULL
>	NULL
``	NULL
and	NULL
this	NULL
population	NULL
was	NULL
further	NULL
enriched	NULL
to	NULL
more	NULL
than	NULL
95	NULL
%	NULL
purity	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
)	NULL
by	NULL
additional	NULL
selection	NULL
with	NULL
immunomagnetic	NULL
beads	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
us	NULL
.	NULL

``	NULL
``	NULL
!	NULL

Gel-filtered	NULL
platelets	NULL
were	NULL
prepared	NULL
from	NULL
4	NULL
persons	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
and	NULL
used	NULL
within	NULL
2	NULL
hours	NULL
of	NULL
preparation	NULL
.	NULL

Marrow	NULL
aspiration	NULL
from	NULL
and	NULL
blood	NULL
donation	NULL
by	NULL
healthy	NULL
volunteers	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
donors	NULL
'	NULL
informed	NULL
consent	NULL
obtained	NULL
through	NULL
the	NULL
Institutional	NULL
Review	NULL
Board	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
and	NULL
detection	NULL
of	NULL
apoptosis	NULL
by	NULL
Annexin	NULL
V	NULL
binding	NULL
assay	NULL
,	NULL
caspase-3	NULL
activation	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
cleavage	NULL
DNA	NULL
content	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
cell	NULL
cycling	NULL
was	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
«	NULL
p	NULL
,	NULL
B	NULL
;	NULL
3+*	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
106	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
appropriate	NULL
ligands	NULL
(	NULL
IL-3	NULL
,	NULL
TPO	NULL
,	NULL
or	NULL
SDF-1	NULL
@	NULL
or	NULL
B	NULL
)	NULL
and	NULL
after	NULL
fixation	NULL
were	NULL
spun	NULL
down	NULL
;	NULL
250	NULL
to	NULL
500	NULL
.L	NULL
RNase	NULL
(	NULL
50	NULL
g/mL	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
[	NULL
PBS	NULL
]	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
(	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
minutes	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
250	NULL
to	NULL
500	NULL
L	NULL
propidium	NULL
iodine	NULL
solution	NULL
(	NULL
50	NULL
pg/mL	NULL
in	NULL
sodium	NULL
citrate	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
before	NULL
reincubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
using	NULL
FACstar	NULL
and	NULL
the	NULL
Cell	NULL
Quest	NULL
program	NULL
.	NULL

Apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
staining	NULL
with	NULL
FITC-Annexin	NULL
V	NULL
and	NULL
flow	NULL
cytometric	NULL
analysis	NULL
(	NULL
FACScan	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
by	NULL
using	NULL
the	NULL
apoptosis	NULL
detection	NULL
kit	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Activation	NULL
of	NULL
caspase-3	NULL
and	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
polymerase	NULL
(	NULL
PARP	NULL
)	NULL
cleavage	NULL
was	NULL
determined	NULL
by	NULL
FACS	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
respectively	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturers	NULL
'	NULL
protocols	NULL
(	NULL
BD	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cellular	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
telomerase	NULL
activity	NULL
using	NULL
the	NULL
PCR-based	NULL
telomeric	NULL
repeat	NULL
amplification	NULL
protocol	NULL
assay	NULL
as	NULL
described	NULL
.	NULL
``	NULL

SDF-1	NULL
AND	NULL
TPO	NULL
IN	NULL
MEGAKARYOPOIESIS	NULL
-	NULL
4143	NULL
Chemotaxis	NULL
,	NULL
trans-Matrige	NULL
!	NULL

migration	NULL
,	NULL
Ca	NULL
2+	NULL
fluxes	NULL
,	NULL
and	NULL
MMP	NULL
and	NULL
VEGF	NULL
production	NULL
Chemotaxis	NULL
assays	NULL
to	NULL
SDF-1	NULL
(	NULL
PeproTech	NULL
,	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
or	NULL
TPO	NULL
(	NULL
R	NULL
&	NULL
D	NULL
)	NULL
through	NULL
an	NULL
8-jm	NULL
pore	NULL
filter	NULL
were	NULL
performed	NULL
in	NULL
Costar-Transwell	NULL
24-well	NULL
plate	NULL
(	NULL
Costar	NULL
Corning	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
as	NULL
described	NULL
before	NULL
.	NULL
``	NULL

''	NULL
Results	NULL
were	NULL
calculated	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
input	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Chemoattraction	NULL
of	NULL
megakaryoblasts	NULL
across	NULL
Matrigel	NULL
was	NULL
evaluated	NULL
in	NULL
a	NULL
trans-Matrigel	NULL
migration	NULL
assay	NULL
according	NULL
to	NULL
a	NULL
method	NULL
previously	NULL
described	NULL
by	NULL
us	NULL
.	NULL

>	NULL
``	NULL
>	NULL
5	NULL
The	NULL
lower	NULL
chambers	NULL
were	NULL
filled	NULL
with	NULL
migration	NULL
media	NULL
containing	NULL
100	NULL
ng/mL	NULL
SDF-1a	NULL
or	NULL
TPO	NULL
,	NULL
and	NULL
percentage	NULL
migration	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
lower	NULL
compartment	NULL
to	NULL
the	NULL
total	NULL
number	NULL
of	NULL
cells	NULL
loaded	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
MMPs	NULL
,	NULL
specifically	NULL
MMP-2	NULL
and	NULL
MMP-9	NULL
,	NULL
in	NULL
trans-Matrigel	NULL
migration	NULL
,	NULL
megakaryoblasts	NULL
were	NULL
preincubated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
10	NULL
g/mL	NULL
MMP	NULL
inhibitors	NULL
rhTIMP-1	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
Dylan	NULL
Edwards	NULL
,	NULL
University	NULL
of	NULL
East	NULL
Anglia	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
or	NULL
thTIMP-2	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
Rafael	NULL
Fridman	NULL
,	NULL
Wayne	NULL
State	NULL
University	NULL
,	NULL
Detroit	NULL
,	NULL
MI	NULL
)	NULL
before	NULL
they	NULL
were	NULL
loaded	NULL
onto	NULL
Boyden	NULL
chambers	NULL
,	NULL
and	NULL
the	NULL
trans-Matrigel	NULL
migration	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
before	NULL
.	NULL

To	NULL
evaluate	NULL
MMP	NULL
secretion	NULL
by	NULL
megakaryoblastic	NULL
cells	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
cells/mL	NULL
were	NULL
incubated	NULL
(	NULL
for	NULL
3-24	NULL
hours	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
ng/mL	NULL
SDF-1	NULL
or	NULL
TPO	NULL
,	NULL
and	NULL
the	NULL
cell-conditioned	NULL
media	NULL
were	NULL
analyzed	NULL
immediately	NULL
by	NULL
zymography	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
The	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
quantified	NULL
using	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
ScionImage	NULL
for	NULL
Windows	NULL
software	NULL
(	NULL
Scion	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Ca**	NULL
flux	NULL
studies	NULL
on	NULL
ex	NULL
vivo-expanded	NULL
megakaryoblasts	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
spectrophotofluorimeter	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

``	NULL
``	NULL
*	NULL
``	NULL
Secretion	NULL
of	NULL
VEGF	NULL
by	NULL
normal	NULL
human	NULL
megakaryoblastic	NULL
cells	NULL
was	NULL
evaluated	NULL
by	NULL
the	NULL
Quantikine	NULL
human	NULL
VEGF	NULL
immunoassay	NULL
(	NULL
R	NULL
&	NULL
D	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
,	NULL
as	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Receptor	NULL
activation	NULL
and	NULL
adherence	NULL
assays	NULL
Activation	NULL
of	NULL
on	NULL
,	NULL
B3	NULL
receptors	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
MoAb	NULL
PAC-1	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
o	NULL
,	NULL
Bs*	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
50	NULL
pL	NULL
PBS	NULL
plus	NULL
2	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
appropriate	NULL
ligands	NULL
:	NULL
thrombin	NULL
(	NULL
2	NULL
U/mL	NULL
)	NULL
,	NULL
SDF-1	NULL
«	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
,	NULL
or	NULL
TPO	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
5	NULL
minutes	NULL
.	NULL

Subsequently	NULL
,	NULL
20	NULL
L	NULL
FITC-conjugated	NULL
PAC-1	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
to	NULL
20	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

RGDS	NULL
peptide*	NULL
``	NULL
was	NULL
added	NULL
to	NULL
confirm	NULL
specific	NULL
binding	NULL
of	NULL
PAC-1	NULL
antibody	NULL
.	NULL

After	NULL
staining	NULL
,	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACstar	NULL
and	NULL
the	NULL
Cell	NULL
Quest	NULL
program	NULL
.	NULL

Adherence	NULL
assays	NULL
of	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

In	NULL
brief	NULL
,	NULL
96-microtiter	NULL
plates	NULL
(	NULL
Dynatech	NULL
Labs	NULL
)	NULL
were	NULL
covered	NULL
with	NULL
4	NULL
pg/mL	NULL
BSA	NULL
,	NULL
fibrinogen	NULL
,	NULL
vitronectin	NULL
,	NULL
fibronectin	NULL
,	NULL
or	NULL
VCAM-1	NULL
(	NULL
all	NULL
from	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
opp	NULL
@	NULL
s*	NULL
cells	NULL
(	NULL
105	NULL
/mL	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
37°C	NULL
in	NULL
lymphocyte	NULL
suspension	NULL
buffer	NULL
``	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
SDF-1	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
,	NULL
TPO	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
,	NULL
SDF-1	NULL
+	NULL
TPO	NULL
(	NULL
500	NULL
ng/mL	NULL
+	NULL
100	NULL
ng/mL	NULL
)	NULL
,	NULL
2	NULL
U/2	NULL
mL	NULL
thrombin	NULL
or	NULL
IL-3	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

Cell	NULL
suspensions	NULL
(	NULL
100	NULL
pL	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
the	NULL
wells	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
number	NULL
of	NULL
adherent	NULL
cells	NULL
was	NULL
estimated	NULL
by	NULL
using	NULL
the	NULL
colorimetric	NULL
phosphate	NULL
assay	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Phosphorylation	NULL
of	NULL
intracellular	NULL
pathway	NULL
proteins	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
extracts	NULL
prepared	NULL
from	NULL
human	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
,	NULL
which	NULL
were	NULL
kept	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
low	NULL
levels	NULL
of	NULL
BSA	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
to	NULL
render	NULL
the	NULL
cells	NULL
quiescent	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
divided	NULL
and	NULL
stimulated	NULL
with	NULL
optimal	NULL
doses	NULL
of	NULL
SDF-1a	NULL
«	NULL
or	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
or	NULL
TPO	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
to	NULL
2	NULL
hours	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
for	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
in	NULL
M-Per	NULL
lysing	NULL
buffer	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IL	NULL
)	NULL
containing	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
extracted	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
either	NULL
a	NULL
12	NULL
%	NULL
or	NULL
15	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
fractionated	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

``	NULL
%	NULL
``	NULL
*	NULL
Phosphorylation	NULL
of	NULL
each	NULL
of	NULL
the	NULL
intracellular	NULL
kinases-MAPK	NULL
p44/42	NULL
,	NULL
MAPK	NULL
p38	NULL
,	NULL
JNK	NULL
MAPK	NULL
,	NULL
p90	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4144	NULL
__	NULL
MAJKA	NULL
etal	NULL
Table	NULL
1	NULL
.	NULL

CFU-MK	NULL
colony	NULL
formation	NULL
by	NULL
human	NULL
CD34+	NULL
cells	NULL
in	NULL
serum-free	NULL
,	NULL
semisolid	NULL
methylcellulose	NULL
medium	NULL
SDF-1	NULL
TPO	NULL
SDF-1	NULL
+	NULL
TPO	NULL
100	NULL
ng/mL	NULL
25	NULL
ng/ml	NULL
.	NULL

100	NULL
ng/mL	NULL
+	NULL
25	NULL
ng/mL	NULL
CFU-MK	NULL
0	NULL
+	NULL
0	NULL
B7	NULL
+	NULL
26	NULL
89	NULL
+	NULL
31	NULL
Each	NULL
data	NULL
entry	NULL
constitutes	NULL
3	NULL
independent	NULL
clonogenic	NULL
assays	NULL
from	NULL
3	NULL
different	NULL
donors	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
mean	NULL
+	NULL
1	NULL
SD	NULL
.	NULL

CFU-MK	NULL
indicates	NULL
colony-forming	NULL
units-megakaryocyte	NULL
.	NULL

RSK	NULL
,	NULL
AKT	NULL
,	NULL
ELK-1	NULL
and	NULL
STAT-1	NULL
,	NULL
-3	NULL
,	NULL
-5	NULL
,	NULL
and	NULL
-6-was	NULL
detected	NULL
using	NULL
commercial	NULL
mouse	NULL
phosphospecific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
p44/42	NULL
)	NULL
or	NULL
rabbit	NULL
phosphospecific	NULL
polyclonal	NULL
antibodies	NULL
for	NULL
each	NULL
of	NULL
the	NULL
remainders	NULL
(	NULL
all	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
antimouse	NULL
IgG	NULL
or	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
as	NULL
a	NULL
secondary	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blots	NULL
and	NULL
reprobing	NULL
them	NULL
with	NULL
the	NULL
appropriate	NULL
monoclonal	NULL
antibodies	NULL
:	NULL
p42/44	NULL
anti-MAPK	NULL
antibody	NULL
clone	NULL
9102	NULL
,	NULL
anti	NULL
p38	NULL
MAPK	NULL
antibody	NULL
clone	NULL
9212	NULL
,	NULL
an	NULL
anti-JNK	NULL
antibody	NULL
clone	NULL
9252	NULL
,	NULL
an	NULL
anti-AKT	NULL
antibody	NULL
clone	NULL
9272	NULL
,	NULL
an	NULL
anti-ELK-1	NULL
antibody	NULL
clone	NULL
9182	NULL
,	NULL
an	NULL
anti-STAT-3	NULL
9132	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
,	NULL
an	NULL
anti-STAT-1	NULL
sc-464	NULL
and	NULL
STAT-6	NULL
sc-1689	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
an	NULL
anti-STAT-5	NULL
89	NULL
or	NULL
p90	NULL
RSK	NULL
78	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
developed	NULL
with	NULL
an	NULL
ECL	NULL
reagent	NULL
(	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
subsequently	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
(	NULL
HyperFilm	NULL
;	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
exposures	NULL
that	NULL
were	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
densitometer	NULL
(	NULL
Personal	NULL
Densitometer	NULL
SI	NULL
;	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Blocking	NULL
of	NULL
PI-3K	NULL
and	NULL
MEK	NULL
PTI-3K	NULL
and	NULL
MAPK	NULL
p42/244	NULL
activities	NULL
were	NULL
blocked	NULL
by	NULL
selective	NULL
inhibitors	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
PI-3K	NULL
inhibitor	NULL
LY294002	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
the	NULL
MEK	NULL
inhibitor	NULL
UO126	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
each	NULL
of	NULL
these	NULL
compounds	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
SDF-1	NULL
«	NULL
or	NULL
TPO	NULL
stimulation	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
To	NULL
evaluate	NULL
NF-kB	NULL
pathways	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
using	NULL
a	NULL
modified	NULL
method	NULL
of	NULL
Pan	NULL
et	NULL
al	NULL
,	NULL
*	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
was	NULL
performed	NULL
using	NULL
2.5	NULL
ug	NULL
nuclear	NULL
extract	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

*	NULL
'	NULL
Oligonucleotides	NULL
and	NULL
their	NULL
complementary	NULL
strands	NULL
for	NULL
EMSA	NULL
were	NULL
obtained	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

The	NULL
sequences	NULL
were	NULL
a	NULL
consensus	NULL
xB	NULL
site	NULL
(	NULL
underlined	NULL
)	NULL
,	NULL
5'-AGTTGAGGGGACTTTCC	NULL
CAGGC-3	NULL
'	NULL
(	NULL
NF-kB	NULL
)	NULL
.	NULL

442	NULL
[	NULL
y-*2	NULL
PJATP	NULL
(	NULL
greater	NULL
than	NULL
500	NULL
Ci/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
Pharma-cia	NULL
Biotech	NULL
.	NULL

Statistical	NULL
analysis	NULL
Arithmetic	NULL
means	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
our	NULL
FACS	NULL
and	NULL
chemotaxis	NULL
data	NULL
were	NULL
calculated	NULL
on	NULL
a	NULL
Macintosh	NULL
computer	NULL
PowerBase	NULL
180	NULL
(	NULL
Apple	NULL
,	NULL
Cupertino	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
using	NULL
Instat	NULL
1.14	NULL
(	NULL
GraphPad	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
software	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
Results	NULL
SDF-1	NULL
does	NULL
not	NULL
affect	NULL
proliferation	NULL
of	NULL
human	NULL
CFU-MK	NULL
and	NULL
megakaryoblasts	NULL
It	NULL
has	NULL
been	NULL
unknown	NULL
whether	NULL
SDF-1	NULL
stimulates	NULL
human	NULL
CFU-MK	NULL
colony	NULL
formation	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
a	NULL
plasma	NULL
clot	NULL
system	NULL
'	NULL
``	NULL
that	NULL
might	NULL
have	NULL
contained	NULL
confounding	NULL
growth	NULL
factors	NULL
.	NULL

Hence	NULL
,	NULL
to	NULL
remove	NULL
the	NULL
unwanted	NULL
influence	NULL
of	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
in	NULL
a	NULL
serum	NULL
,	NULL
we	NULL
now	NULL
evaluated	NULL
the	NULL
growth	NULL
of	NULL
CFU-MK	NULL
or	NULL
oupBs*	NULL
cells	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
or	NULL
TPO	NULL
in	NULL
cultures	NULL
supplemented	NULL
with	NULL
chemically	NULL
defined	NULL
artificial	NULL
serum	NULL
.	NULL

'*2	NULL
%	NULL
``	NULL
``	NULL
SDF-1	NULL
was	NULL
found	NULL
not	NULL
to	NULL
have	NULL
any	NULL
effect	NULL
,	NULL
either	NULL
on	NULL
its	NULL
own	NULL
or	NULL
acting	NULL
as	NULL
a	NULL
costimulator	NULL
with	NULL
TPO	NULL
,	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
human	NULL
CFU-MK	NULL
colonies	NULL
from	NULL
CD34*	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
when	NULL
human	NULL
megakaryoblastic	NULL
a	NULL
«	NULL
p	NULL
,	NULL
B3*	NULL
cells	NULL
were	NULL
expanded	NULL
ex	NULL
vivo	NULL
from	NULL
CD34	NULL
*	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
suboptimal	NULL
or	NULL
an	NULL
optimal	NULL
dose	NULL
of	NULL
TPO	NULL
+	NULL
IL-3	NULL
)	NULL
and	NULL
SDF-1	NULL
was	NULL
added	NULL
as	NULL
a	NULL
costimulator	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
SDF-1	NULL
to	NULL
affect	NULL
proliferation	NULL
or	NULL
maturation	NULL
of	NULL
these	NULL
cells	NULL
at	NULL
days	NULL
6	NULL
and	NULL
11	NULL
of	NULL
culture	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
number	NULL
of	NULL
oy	NULL
,	NULL
fBs*	NULL
cells	NULL
in	NULL
the	NULL
cultures	NULL
nor	NULL
the	NULL
intensity	NULL
of	NULL
expression	NULL
of	NULL
ay	NULL
,	NULL
3	NULL
;	NULL
*	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
changed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
it	NULL
has	NULL
been	NULL
recently	NULL
suggested	NULL
that	NULL
SDF-1	NULL
may	NULL
stimulate	NULL
proliferation	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
if	NULL
used	NULL
at	NULL
very	NULL
low	NULL
concentrations	NULL
,	NULL
``	NULL
we	NULL
repeated	NULL
these	NULL
experiments	NULL
using	NULL
low	NULL
doses	NULL
of	NULL
SDF-1	NULL
(	NULL
10	NULL
pg	NULL
to	NULL
1	NULL
ng/mL	NULL
)	NULL
and	NULL
still	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
effect	NULL
on	NULL
cell	NULL
proliferation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
of	NULL
megakaryoblasts	NULL
growing	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF-1	NULL
or	NULL
TPO	NULL
was	NULL
also	NULL
undertaken	NULL
.	NULL

The	NULL
ap	NULL
,	NULL
B	NULL
}	NULL
3*	NULL
cells	NULL
expanded	NULL
for	NULL
6	NULL
days	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPO	NULL
+	NULL
IL-3	NULL
)	NULL
were	NULL
transferred	NULL
to	NULL
cultures	NULL
containing	NULL
no	NULL
growth	NULL
factors	NULL
or	NULL
to	NULL
cultures	NULL
supplemented	NULL
with	NULL
TPO	NULL
+	NULL
IL-3	NULL
,	NULL
TPO	NULL
,	NULL
or	NULL
SDF-1	NULL
.	NULL

Within	NULL
24	NULL
hours	NULL
of	NULL
withdrawal	NULL
of	NULL
TPO	NULL
+	NULL
IL-3	NULL
,	NULL
the	NULL
number	NULL
of	NULL
ap	NULL
,	NULL
B	NULL
;	NULL
*	NULL
cells	NULL
in	NULL
the	NULL
S	NULL
and	NULL
Gy/M	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
had	NULL
decreased	NULL
by	NULL
20	NULL
%	NULL
to	NULL
30	NULL
%	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
cultures	NULL
supplemented	NULL
with	NULL
TPO	NULL
+	NULL
IL-3	NULL
or	NULL
TPO	NULL
alone	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

More	NULL
important	NULL
,	NULL
the	NULL
number	NULL
of	NULL
opp	NULL
,	NULL
B3*	NULL
cells	NULL
in	NULL
the	NULL
S	NULL
and	NULL
G	NULL
;	NULL
/M	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
also	NULL
decreased	NULL
(	NULL
by	NULL
approximately	NULL
20	NULL
%	NULL
-30	NULL
%	NULL
)	NULL
in	NULL
the	NULL
cultures	NULL
supplemented	NULL
with	NULL
SDF-1	NULL
,	NULL
as	NULL
in	NULL
the	NULL
cultures	NULL
depleted	NULL
of	NULL
TPO	NULL
and	NULL
IL-3	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
stimulation	NULL
of	NULL
ap	NULL
,	NULL
;	NULL
*	NULL
cells	NULL
by	NULL
SDF-1	NULL
did	NULL
not	NULL
increase	NULL
telomerase	NULL
activity	NULL
tested	NULL
by	NULL
the	NULL
telomeric	NULL
repeat	NULL
amplification	NULL
protocol	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
it	NULL
did	NULL
in	NULL
the	NULL
TPO-stimulated	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
together	NULL
suggest	NULL
that	NULL
,	NULL
unlike	NULL
what	NULL
occurs	NULL
in	NULL
murine	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
SDF-1	NULL
does	NULL
not	NULL
affect	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
.	NULL

SDF-1	NULL
does	NULL
not	NULL
affect	NULL
survival	NULL
of	NULL
human	NULL
ou	NULL
,	NULL
fB	NULL
;	NULL
*	NULL
cells	NULL
TPO	NULL
is	NULL
a	NULL
potent	NULL
antiapoptotic	NULL
factor	NULL
for	NULL
human	NULL
CD34+*	NULL
cells	NULL
,	NULL
``	NULL
erythroid	NULL
progenitors,4**	NULL
``	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
,	NULL
!	NULL

but	NULL
whether	NULL
SDF-1	NULL
influences	NULL
the	NULL
survival	NULL
of	NULL
normal	NULL
human	NULL
cells	NULL
is	NULL
unknown	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
human	NULL
ap	NULL
,	NULL
B3*	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
12	NULL
hours	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
TPO	NULL
or	NULL
SDF-1	NULL
.	NULL

We	NULL
found	NULL
Table	NULL
2	NULL
.	NULL

Lack	NULL
of	NULL
SDF-1	NULL
effect	NULL
on	NULL
TPO	NULL
+	NULL
IL-3-dependent	NULL
proliferation	NULL
of	NULL
human	NULL
CD34+*	NULL
BM	NULL
MNCs	NULL
Suboptimal*	NULL
stimulation	NULL
by	NULL
Suboptimal	NULL
stimulation	NULL
by	NULL
Optimal*	NULL
stimulation	NULL
by	NULL
Optimal	NULL
stimulation	NULL
by	NULL
TPO	NULL
+	NULL
IL-3	NULL
TPO	NULL
+	NULL
IL-3	NULL
+	NULL
SDF-1	NULL
TPO	NULL
+	NULL
IL-3	NULL
TPO	NULL
+	NULL
IL-3	NULL
+	NULL
SDF-1	NULL
Day	NULL
6	NULL
1.2	NULL
+	NULL
0.7	NULL
1.2	NULL
+	NULL
0.8	NULL
2.6	NULL
+	NULL
0.5	NULL
2.7	NULL
+	NULL
0.7	NULL
Day	NULL
11	NULL
3.6	NULL
+	NULL
1.9	NULL
3.5	NULL
+	NULL
2.2	NULL
6.8	NULL
+	NULL
2.8	NULL
6.1	NULL
+	NULL
3.5	NULL
Each	NULL
data	NULL
entry	NULL
consists	NULL
of	NULL
data	NULL
from	NULL
3	NULL
different	NULL
donors	NULL
.	NULL

Data	NULL
shown	NULL
represent	NULL
mean	NULL
+	NULL
1	NULL
SD	NULL
.	NULL

SDF-1	NULL
indicates	NULL
stromal-derived	NULL
factor	NULL
1	NULL
;	NULL
TPO	NULL
,	NULL
thrombopoietin	NULL
;	NULL
IL-3	NULL
,	NULL
interleukin-3	NULL
;	NULL
BM	NULL
MNCs	NULL
,	NULL
bone	NULL
marrow	NULL
mononuclear	NULL
cells	NULL
.	NULL

*CD34*	NULL
cells	NULL
(	NULL
10+	NULL
cells/point	NULL
)	NULL
were	NULL
ex	NULL
vivo	NULL
expanded	NULL
toward	NULL
megakaryoblasts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPO	NULL
+	NULL
IL-3	NULL
at	NULL
suboptimal	NULL
doses	NULL
(	NULL
10	NULL
ng/mL	NULL
+	NULL
5	NULL
U/mL	NULL
)	NULL
or	NULL
optimal	NULL
doses	NULL
(	NULL
50	NULL
ng/mL	NULL
.	NULL

+	NULL
20	NULL
U/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
SDF-1	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
that	NULL
cells	NULL
that	NULL
were	NULL
withdrawn	NULL
from	NULL
TPO	NULL
+	NULL
IL-3	NULL
underwent	NULL
apoptosis	NULL
after	NULL
12	NULL
hours	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
an	NULL
Annexin	NULL
V	NULL
binding	NULL
assay	NULL
(	NULL
Figure	NULL
1Ai	NULL
)	NULL
.4	NULL
``	NULL
The	NULL
presence	NULL
of	NULL
TPO	NULL
in	NULL
the	NULL
culture	NULL
media	NULL
prevented	NULL
these	NULL
cells	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
Figure	NULL
1	NULL
Aii	NULL
)	NULL
,	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
SDF-1	NULL
did	NULL
not	NULL
(	NULL
Figure	NULL
1Aiii	NULL
)	NULL
.	NULL

Megakaryoblastic	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF-1	NULL
bound	NULL
Annexin	NULL
V	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
cells	NULL
cultured	NULL
without	NULL
TPO	NULL
+	NULL
IL-3	NULL
(	NULL
Figure	NULL
1Aiii	NULL
)	NULL
.	NULL

These	NULL
data	NULL
clearly	NULL
indicate	NULL
that	NULL
SDF-1	NULL
does	NULL
not	NULL
maintain	NULL
or	NULL
enhance	NULL
megakaryopoiesis	NULL
.	NULL

Because	NULL
PI-3K	NULL
(	NULL
a	NULL
potential	NULL
target	NULL
for	NULL
TPO	NULL
signaling	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
inhibiting	NULL
apoptosis	NULL
in	NULL
human	NULL
hematopoietic	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
were	NULL
exposed	NULL
to	NULL
the	NULL
PI-3K	NULL
inhibitor	NULL
LY294002	NULL
,	NULL
and	NULL
we	NULL
found	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
PI-3K	NULL
activity	NULL
resulted	NULL
in	NULL
increases	NULL
in	NULL
Annexin	NULL
V	NULL
binding	NULL
of	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
caspase-3	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
and	NULL
PARP	NULL
cleavage	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
MAPK	NULL
p42/44	NULL
pathway	NULL
by	NULL
the	NULL
MEK	NULL
inhibitor	NULL
(	NULL
UO126	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
survival	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

SDF-1	NULL
but	NULL
not	NULL
TPO	NULL
induces	NULL
Ca++	NULL
flux	NULL
,	NULL
chemotaxis	NULL
,	NULL
trans-Matrige	NULL
!	NULL

chemoattraction	NULL
,	NULL
MMP-9	NULL
,	NULL
and	NULL
VEGF	NULL
production	NULL
Next	NULL
we	NULL
extended	NULL
our	NULL
studies	NULL
to	NULL
define	NULL
the	NULL
roles	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
in	NULL
the	NULL
homing	NULL
of	NULL
human	NULL
megakaryoblastic	NULL
cells	NULL
by	NULL
examining	NULL
their	NULL
effects	NULL
on	NULL
chemotaxis	NULL
,	NULL
Ca**	NULL
fluxes	NULL
,	NULL
trans-Matrigel	NULL
chemoattraction	NULL
,	NULL
and	NULL
production	NULL
of	NULL
MMP	NULL
and	NULL
VEGE	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
that	NULL
SDF-1	NULL
induces	NULL
Ca+*	NULL
flux	NULL
in	NULL
human	NULL
megakaryoblasts	NULL
,	NULL
'	NULL
``	NULL
and	NULL
TPO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
the	NULL
platelet	NULL
reactivity	NULL
of	NULL
other	NULL
agonists	NULL
.	NULL
``	NULL

Because	NULL
the	NULL
chemotactic	NULL
ability	NULL
of	NULL
TPO	NULL
had	NULL
not	NULL
yet	NULL
been	NULL
studied	NULL
in	NULL
human	NULL
megakaryoblasts	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
TPO	NULL
could	NULL
induce	NULL
Ca	NULL
**	NULL
flux	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

A	NULL
(	NULL
+SDF-1	NULL
)	NULL
(	NULL
~	NULL
)	NULL
(	NULL
+TPO	NULL
)	NULL
TPO	NULL
+	NULL
LY	NULL
294002	NULL
TPO	NULL
+	NULL
LY	NULL
294002	NULL
10	NULL
pmol/L	NULL
30	NULL
pmol/L	NULL
%	NULL
8	NULL
o	NULL
a	NULL
#	NULL
3	NULL
ai	NULL
a	NULL
o	NULL
REE	NULL
£8	NULL
$	NULL
s	NULL
)	NULL
|	NULL
H	NULL
§	NULL
]	NULL
|	NULL
88	NULL
BH	NULL
M1	NULL
g	NULL
o	NULL
;	NULL
o	NULL
wow	NULL
e	NULL
as	NULL
ant	NULL
RBH	NULL
1	NULL
2	NULL
3	NULL
Figure	NULL
1	NULL
.	NULL

SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
survival	NULL
of	NULL
normal	NULL
human	NULL
cells	NULL
but	NULL
activates	NULL
calcium	NULL
flux	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Annexin	NULL
V	NULL
binding	NULL
to	NULL
human	NULL
cuBs+*	NULL
cells	NULL
cultured	NULL
for	NULL
12	NULL
hours	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
growth	NULL
factors	NULL
(	NULL
i	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
ii	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
iii	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
3	NULL
is	NULL
demonstrated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Detection	NULL
of	NULL
activated	NULL
caspase-3	NULL
in	NULL
normal	NULL
human	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPO	NULL
,	NULL
TPO	NULL
+	NULL
LY294002	NULL
(	NULL
10	NULL
mol/L	NULL
)	NULL
,	NULL
and	NULL
TPO	NULL
+	NULL
LY294002	NULL
(	NULL
30	NULL
mol/L	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
3	NULL
is	NULL
demonstrated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Detection	NULL
of	NULL
PARP	NULL
cleavage	NULL
in	NULL
normal	NULL
human	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPO	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
TPO	NULL
+	NULL
DMSO	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
TPO	NULL
+	NULL
LY294002	NULL
(	NULL
30	NULL
umol/L	NULL
)	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
of	NULL
3	NULL
is	NULL
demonstrated	NULL
.	NULL

SDF-1	NULL
AND	NULL
TPO	NULL
IN	NULL
MEGAKARYOPOIESIS	NULL
-	NULL
4145	NULL
Cs	NULL
p	NULL
i=	NULL
f	NULL
'	NULL
i	NULL
An	NULL
a	NULL
ou	NULL
&	NULL
a	NULL
w	NULL
os	NULL
w	NULL
s	NULL
ome	NULL
Tpo	NULL
sDF4	NULL
30	NULL
,	NULL
30	NULL
g	NULL
25	NULL
|	NULL
g	NULL
25	NULL
a	NULL
20	NULL
|	NULL
g	NULL
20	NULL
)	NULL
_	NULL
§	NULL
15	NULL
)	NULL
$	NULL
15	NULL
|	NULL
§	NULL
10	NULL
)	NULL
g	NULL
10	NULL
I	NULL
.	NULL

&	NULL
&	NULL
0	NULL
§	NULL
0	NULL
5	NULL
l	NULL
0	NULL
|_c*	NULL
==	NULL
c	NULL
#	NULL
o-	NULL
0	NULL
}	NULL
--	NULL
-	NULL
%	NULL
Upper	NULL
-	NULL
~	NULL
a	NULL
~	NULL
~	NULL
C	NULL
_	NULL
SDF4	NULL
oly	NULL
Ly	NULL
=	NULL
m	NULL
&	NULL
Z	NULL
a	NULL
so	NULL
Lower	NULL
-	NULL
_	NULL
TPO	NULL
TPO	NULL
TPO	NULL
SDF1	NULL
neromisNse	NULL
5	NULL
50	NULL
_	NULL
100	NULL
_	NULL
300	NULL
(	NULL
ng/imL	NULL
)	NULL
20	NULL
,	NULL
3	NULL
es	NULL
20	NULL
k	NULL
o	NULL
a	NULL
&	NULL
3	NULL
``	NULL
8	NULL
$	NULL
&	NULL
&	NULL
a	NULL
§	NULL
10	NULL
&	NULL
mmp-9	NULL
a	NULL
®	NULL
*	NULL
&	NULL
58	NULL
s	NULL
)	NULL
Ef	NULL
'	NULL
|	NULL
|—'—	NULL
.	NULL

MMP-2-+	NULL
»	NULL
0	NULL
I_	NULL
,	NULL
I_	NULL
,	NULL
I	NULL
T	NULL
R	NULL
TPO	NULL
SDF-1	NULL
SDF-1	NULL
SDF	NULL
§	NULL
12	NULL
&	NULL
§§1nn	NULL
I1	NULL
Std	NULL
10	NULL
2	NULL
=	NULL
80	NULL
I	NULL
E	NULL
é	NULL
so	NULL
MMP-93-	NULL
»	NULL
-	NULL
®	NULL
40	NULL
E	NULL
2	NULL
29	NULL
.	NULL

MMP	NULL
-2-	NULL
»	NULL
2	NULL
``	NULL
0	NULL
&	NULL
SDF1	NULL
Ly	NULL
Ly	NULL
(	NULL
10	NULL
.	NULL

(	NULL
30	NULL
pmol	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

SDF-1	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
activates	NULL
calcium	NULL
flux	NULL
,	NULL
chemotaxis	NULL
,	NULL
trans-Matrige	NULL
!	NULL

migration	NULL
,	NULL
and	NULL
MMP-9	NULL
production	NULL
in	NULL
normal	NULL
human	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Calcium	NULL
flux	NULL
studies	NULL
of	NULL
Fura-2-loaded	NULL
normal	NULL
human	NULL
cells	NULL
.	NULL

TPO	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
or	NULL
SDF-1	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
subsequently	NULL
calcium	NULL
flux	NULL
was	NULL
evaluated	NULL
by	NULL
a	NULL
spectrophotofluorimeter	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
repeated	NULL
3	NULL
times	NULL
and	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Normal	NULL
human	NULL
cells	NULL
show	NULL
chemotaxis	NULL
to	NULL
SDF-1	NULL
but	NULL
not	NULL
to	NULL
TPO	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
in	NULL
duplicate	NULL
.	NULL

The	NULL
bottom	NULL
chambers	NULL
contained	NULL
media	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
or	NULL
5	NULL
to	NULL
100	NULL
ng/mL	NULL
.	NULL

TPO	NULL
or	NULL
300	NULL
ng/mL	NULL
SDF-1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Inhibition	NULL
of	NULL
SDF-1-dependent	NULL
chemotaxis	NULL
after	NULL
preincubation	NULL
of	NULL
megakaryoblasts	NULL
with	NULL
increasing	NULL
concentration	NULL
of	NULL
LY294002	NULL
(	NULL
10	NULL
mol/L	NULL
and	NULL
30	NULL
wmol/L	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
in	NULL
duplicate	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Trans-Matrige	NULL
!	NULL

migration	NULL
of	NULL
megakaryoblasts	NULL
toward	NULL
SDF-1	NULL
and	NULL
TPO	NULL
gradients	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
MMP	NULL
inhibitors	NULL
.	NULL

The	NULL
bottom	NULL
chambers	NULL
contained	NULL
media	NULL
alone	NULL
(	NULL
control	NULL
,	NULL
c	NULL
)	NULL
or	NULL
100	NULL
ng/mL	NULL
each	NULL
of	NULL
SDF-1	NULL
or	NULL
TPO	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
twice	NULL
using	NULL
4	NULL
to	NULL
5	NULL
chambers	NULL
.	NULL

Inhibition	NULL
of	NULL
trans-Matrige	NULL
!	NULL

migration	NULL
toward	NULL
SDF-1	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
preincubating	NULL
the	NULL
megakaryoblasts	NULL
for	NULL
2	NULL
hours	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
g/mL	NULL
rhTIMP-1	NULL
or	NULL
rhTIMP-2	NULL
.	NULL

Percentages	NULL
of	NULL
cells	NULL
that	NULL
migrated	NULL
after	NULL
3	NULL
hours	NULL
of	NULL
incubation	NULL
at	NULL
37°C	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
1	NULL
SD	NULL
.	NULL

(	NULL
E	NULL
)	NULL
MMP	NULL
expression	NULL
in	NULL
megakaryoblasts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
.	NULL

Media	NULL
conditioned	NULL
by	NULL
megakaryoblasts	NULL
after	NULL
incubation	NULL
for	NULL
3	NULL
hours	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
control	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
100	NULL
ng/mL	NULL
SDF-1	NULL
or	NULL
TPO	NULL
were	NULL
analyzed	NULL
by	NULL
zymography	NULL
.	NULL

Media	NULL
conditioned	NULL
by	NULL
KG-1	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
the	NULL
standard	NULL
to	NULL
show	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
MMP-9	NULL
and	NULL
MMP-2	NULL
activities	NULL
in	NULL
the	NULL
gel	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
.	NULL

(	NULL
F	NULL
)	NULL
Inhibition	NULL
of	NULL
trans-Matrige	NULL
!	NULL

migration	NULL
to	NULL
SDF-1	NULL
after	NULL
preincubation	NULL
of	NULL
megakaryoblasts	NULL
with	NULL
increasing	NULL
concentration	NULL
of	NULL
LY294002	NULL
(	NULL
10	NULL
mol/L	NULL
and	NULL
30	NULL
mol/L	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
twice	NULL
,	NULL
using	NULL
6	NULL
chambers	NULL
each	NULL
.	NULL

(	NULL
G	NULL
)	NULL
MMP	NULL
expression	NULL
in	NULL
megakaryoblasts	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
without	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
LY294002	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
2	NULL
times	NULL
.	NULL

We	NULL
found	NULL
that	NULL
in	NULL
comparison	NULL
with	NULL
SDF-1	NULL
,	NULL
which	NULL
stimulated	NULL
a	NULL
measurable	NULL
Ca++	NULL
flux	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
TPO	NULL
added	NULL
at	NULL
various	NULL
concentrations	NULL
(	NULL
physiological	NULL
and	NULL
high	NULL
)	NULL
did	NULL
not	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
having	NULL
previously	NULL
shown	NULL
that	NULL
SDF-1	NULL
is	NULL
a	NULL
strong	NULL
chemoattractant	NULL
for	NULL
human	NULL
megakaryocytes	NULL
,	NULL
``	NULL
we	NULL
examined	NULL
whether	NULL
TPO	NULL
could	NULL
attract	NULL
these	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

We	NULL
found	NULL
that	NULL
TPO	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
SDF-1	NULL
,	NULL
did	NULL
not	NULL
attract	NULL
human	NULL
ap	NULL
,	NULL
B	NULL
;	NULL
*	NULL
cells	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
``	NULL
SDF-1-induced	NULL
chemotaxis	NULL
was	NULL
inhibited	NULL
by	NULL
LY294002	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
but	NULL
not	NULL
by	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4146	NULL
_	NULL
MAJKA	NULL
etal	NULL
UO126	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
PI-3K	NULL
in	NULL
this	NULL
process	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
SDF-1	NULL
gradient	NULL
,	NULL
unlike	NULL
a	NULL
TPO	NULL
gradient	NULL
,	NULL
attracted	NULL
oup	NULL
,	NULL
B	NULL
;	NULL
*	NULL
cells	NULL
across	NULL
the	NULL
reconstituted	NULL
basement	NULL
membrane	NULL
Matrigel	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
,	NULL
and	NULL
the	NULL
MMP	NULL
inhibitors	NULL
(	NULL
rhTIMP-1	NULL
and	NULL
rhTIMP-2	NULL
)	NULL
reduced	NULL
this	NULL
trans-Matrigel	NULL
chemotaxis	NULL
by	NULL
68	NULL
%	NULL
+	NULL
8	NULL
%	NULL
and	NULL
52	NULL
%	NULL
+	NULL
11	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
2D	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
MMPs	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
process	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
whether	NULL
ouy	NULL
,	NULL
B3*	NULL
cells	NULL
secrete	NULL
MMPs	NULL
,	NULL
especially	NULL
MMP-9	NULL
and	NULL
MMP-2	NULL
,	NULL
and	NULL
demonstrated	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
megakaryocytic	NULL
cells	NULL
constitutively	NULL
secrete	NULL
MMP-9	NULL
and	NULL
that	NULL
SDF-1	NULL
increases	NULL
this	NULL
secretion	NULL
slightly	NULL
(	NULL
Figure	NULL
2E	NULL
)	NULL
.	NULL

SDF-1-induced	NULL
trans-Matrigel	NULL
migration	NULL
and	NULL
MMP-9	NULL
secretion	NULL
were	NULL
inhibited	NULL
when	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
LY	NULL
29002	NULL
(	NULL
Figure	NULL
2F	NULL
,	NULL
G	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
PI-3K	NULL
in	NULL
both	NULL
processes	NULL
.	NULL

Because	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
secrete	NULL
VEGF	NULL
``	NULL
and	NULL
because	NULL
endogenously	NULL
secreted	NULL
VEGF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
megakaryocytes	NULL
,	NULL
``	NULL
we	NULL
next	NULL
evaluated	NULL
whether	NULL
SDF-1	NULL
or	NULL
TPO	NULL
has	NULL
any	NULL
effect	NULL
on	NULL
the	NULL
secretion	NULL
of	NULL
VEGF	NULL
by	NULL
normal	NULL
human	NULL
cells	NULL
.	NULL

Table	NULL
3	NULL
shows	NULL
that	NULL
SDF-1	NULL
,	NULL
but	NULL
not	NULL
TPO	NULL
,	NULL
significantly	NULL
stimulates	NULL
the	NULL
secretion	NULL
of	NULL
VEGF	NULL
by	NULL
these	NULL
cells	NULL
.	NULL

Cells	NULL
that	NULL
have	NULL
been	NULL
preincubated	NULL
with	NULL
LY294002	NULL
,	NULL
but	NULL
not	NULL
with	NULL
UO126	NULL
,	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
SDF-1	NULL
stimulation	NULL
with	NULL
increased	NULL
VEGF	NULL
secretion	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

SDF-1	NULL
and	NULL
TPO	NULL
activate	NULL
oy	NULL
,	NULL
fs	NULL
and	NULL
«	NULL
VB3	NULL
integrins	NULL
and	NULL
adhesion	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
to	NULL
fibrinogen	NULL
and	NULL
vitronectin	NULL
Adkesion	NULL
to	NULL
extracellular	NULL
ligands	NULL
is	NULL
an	NULL
important	NULL
step	NULL
in	NULL
megakaryocyte	NULL
migration	NULL
.	NULL

Using	NULL
the	NULL
PAC-1	NULL
binding	NULL
assay	NULL
,	NULL
``	NULL
``	NULL
we	NULL
demonstrated	NULL
that	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
activate	NULL
ap	NULL
,	NULL
B3	NULL
integrin	NULL
on	NULL
human	NULL
megakaryoblasts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
findings	NULL
by	NULL
others	NULL
that	NULL
TPO	NULL
enhances	NULL
platelet	NULL
reactivity	NULL
``	NULL
'	NULL
and	NULL
with	NULL
our	NULL
recent	NULL
observations	NULL
that	NULL
SDF-1	NULL
also	NULL
stimulates	NULL
it	NULL
.	NULL
``	NULL

''	NULL
Consistent	NULL
with	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
found	NULL
that	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
increased	NULL
the	NULL
adherence	NULL
of	NULL
ojp,33	NULL
cells	NULL
to	NULL
fibrinogen	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Both	NULL
cytokines	NULL
,	NULL
if	NULL
added	NULL
together	NULL
,	NULL
also	NULL
induced	NULL
adhesiveness	NULL
to	NULL
vitronectin	NULL
(	NULL
Figures	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
adhesion	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
was	NULL
inhibited	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
the	NULL
PI-3K	NULL
inhibitor	NULL
,	NULL
suggesting	NULL
again	NULL
the	NULL
involvement	NULL
of	NULL
PI-3K	NULL
in	NULL
this	NULL
process	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
adhesion	NULL
of	NULL
human	NULL
differentiating	NULL
ap	NULL
,	NULL
fB3	NULL
*	NULL
cells	NULL
to	NULL
fibronectin	NULL
and	NULL
VCAM-1	NULL
was	NULL
weak	NULL
and	NULL
not	NULL
affected	NULL
by	NULL
SDF-1	NULL
or	NULL
TPO	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
increase	NULL
the	NULL
adhesion	NULL
of	NULL
megakaryoblasts	NULL
to	NULL
their	NULL
microenvironment	NULL
.	NULL

Phosphorylation	NULL
of	NULL
MAPK	NULL
(	NULL
p42/44	NULL
and	NULL
p38	NULL
)	NULL
and	NULL
AKT	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
is	NULL
induced	NULL
by	NULL
SDF-1	NULL
and	NULL
TPO	NULL
To	NULL
explain	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
different	NULL
biologic	NULL
effects	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
induced	NULL
by	NULL
these	NULL
cytokines	NULL
in	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
intracellular	NULL
kinase	NULL
MAPK	NULL
p42/44	NULL
is	NULL
Table	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
on	NULL
VEGF	NULL
secretion	NULL
by	NULL
human	NULL
megakaryoblasts	NULL
(	NULL
10°	NULL
cells/mL	NULL
)	NULL
cultured	NULL
for	NULL
24	NULL
hours	NULL
in	NULL
serum-free	NULL
medium	NULL
(	NULL
-	NULL
)	NULL
SDF-1	NULL
100	NULL
ng/mL	NULL
TPO	NULL
100	NULL
ng/mL	NULL
VEGF	NULL
(	NULL
pg/imL	NULL
)	NULL
*	NULL
119	NULL
+	NULL
28	NULL
315	NULL
+	NULL
69+	NULL
134	NULL
+	NULL
37	NULL
Each	NULL
data	NULL
entry	NULL
consists	NULL
of	NULL
2	NULL
independent	NULL
measurements	NULL
from	NULL
3	NULL
different	NULL
donors	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
mean	NULL
+	NULL
1	NULL
SD	NULL
.	NULL

*	NULL
SDF-1	NULL
indicates	NULL
stromal-derived	NULL
factor	NULL
1	NULL
;	NULL
TPO	NULL
,	NULL
thrombopoietin	NULL
;	NULL
VEGF	NULL
,	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
.	NULL

*Sensitivity	NULL
of	NULL
the	NULL
ELISA	NULL
assay	NULL
for	NULL
VEGF	NULL
was	NULL
>	NULL
5	NULL
pg/mL	NULL
.	NULL

{	NULL
P	NULL
<	NULL
.0001	NULL
compared	NULL
to	NULL
(	NULL
-	NULL
)	NULL
and	NULL
TPO	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
Boweat	NULL
mS0F	NULL
GSDF	NULL
+	NULL
Ly	NULL
254002	NULL
umoU/L	NULL
|	NULL
|	NULL
BTP	NULL
|	NULL
m	NULL
TPO	NULL
+	NULL
ty	NULL
254002	NULL
30umoi/L	NULL
.	NULL

mSOF+TPO	NULL
+	NULL
Ly	NULL
264002	NULL
20umoi/	NULL
.	NULL

OD	NULL
[	NULL
405	NULL
nm	NULL
]	NULL
o	NULL
8	NULL
c	NULL
8	NULL
Thrombin	NULL
Vitronectin	NULL
BSA	NULL
Fibrinogen	NULL
Figure	NULL
3	NULL
.	NULL

SDF-1	NULL
and	NULL
TPO	NULL
stimulate	NULL
adhesion	NULL
of	NULL
normal	NULL
human	NULL
op	NULL
,	NULL
B	NULL
&	NULL
*	NULL
cells	NULL
to	NULL
fibrinogen	NULL
and	NULL
vitronectin	NULL
.	NULL

Adhesion	NULL
was	NULL
measured	NULL
to	NULL
BSA-	NULL
(	NULL
control	NULL
)	NULL
,	NULL
fibrinogen-	NULL
,	NULL
and	NULL
vitronectin-coated	NULL
microtiter	NULL
plates	NULL
.	NULL

Cells	NULL
in	NULL
the	NULL
adhesion	NULL
assay	NULL
were	NULL
nonstimulated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
,	NULL
100	NULL
ng/mL	NULL
TPO	NULL
,	NULL
500	NULL
ng	NULL
SDF-1	NULL
+	NULL
100	NULL
ng	NULL
TPO	NULL
,	NULL
2	NULL
U/mL	NULL
thrombin	NULL
,	NULL
or	NULL
100	NULL
ng/mL	NULL
IL-3	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cells	NULL
stuck	NULL
to	NULL
the	NULL
plates	NULL
was	NULL
quantified	NULL
by	NULL
colorimetric	NULL
phosphatase	NULL
assay	NULL
.	NULL

Y	NULL
axis	NULL
:	NULL
OD	NULL
values	NULL
at	NULL
405	NULL
nm	NULL
.	NULL

Experiments	NULL
were	NULL
repeated	NULL
3	NULL
times	NULL
in	NULL
triplicate	NULL
,	NULL
yielding	NULL
similar	NULL
results	NULL
.	NULL

*	NULL
and	NULL
*P	NULL
<	NULL
.0001	NULL
compared	NULL
to	NULL
control	NULL
.	NULL

*	NULL
and	NULL
**P	NULL
<	NULL
.0001	NULL
compared	NULL
to	NULL
cells	NULL
untreated	NULL
with	NULL
LY294002	NULL
.	NULL

phosphorylated	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
,	NULL
platelets	NULL
,	NULL
and	NULL
murine	NULL
megakaryoblasts	NULL
after	NULL
stimulation	NULL
by	NULL
both	NULL
TPO	NULL
or	NULL
SDF-1.2	NULL
>	NULL
``	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
MAP	NULL
kinases	NULL
(	NULL
p42/44	NULL
,	NULL
p38	NULL
,	NULL
and	NULL
JNK	NULL
)	NULL
that	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
cell	NULL
proliferation	NULL
,	NULL
``	NULL
including	NULL
the	NULL
intensity	NULL
and	NULL
kinetics	NULL
of	NULL
their	NULL
activation	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
.	NULL

We	NULL
found	NULL
that	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
induced	NULL
strong	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
;	NULL
however	NULL
,	NULL
after	NULL
stimulation	NULL
with	NULL
SDF-1	NULL
,	NULL
it	NULL
was	NULL
phosphorylated	NULL
faster	NULL
than	NULL
with	NULL
TPO	NULL
(	NULL
peak	NULL
at	NULL
1	NULL
minute	NULL
for	NULL
SDF-1	NULL
vs	NULL
10	NULL
minutes	NULL
for	NULL
TPO	NULL
)	NULL
and	NULL
more	NULL
intensely	NULL
(	NULL
21-	NULL
+	NULL
6-	NULL
vs	NULL
11-	NULL
+	NULL
3-fold	NULL
increases	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

We	NULL
correctly	NULL
predicted	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
should	NULL
lead	NULL
to	NULL
phosphorylation	NULL
of	NULL
several	NULL
MAPK	NULL
substrates	NULL
(	NULL
p90	NULL
RSK	NULL
and	NULL
ELK-1	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
confirmed	NULL
for	NULL
p90	NULL
RSK	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
and	NULL
ELK-1	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
though	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
stimulated	NULL
strong	NULL
phosphorylation	NULL
of	NULL
both	NULL
substrates	NULL
,	NULL
SDF-1	NULL
induced	NULL
an	NULL
earlier	NULL
and	NULL
more	NULL
intense	NULL
response	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
whether	NULL
other	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
family	NULL
(	NULL
p38	NULL
,	NULL
JNK	NULL
)	NULL
are	NULL
activated	NULL
in	NULL
ap	NULL
,	NULL
cells	NULL
by	NULL
either	NULL
TPO	NULL
or	NULL
SDF-1	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
ayy	NULL
3	NULL
;	NULL
*	NULL
cells	NULL
were	NULL
made	NULL
quiescent	NULL
by	NULL
BSA	NULL
starvation	NULL
and	NULL
subsequently	NULL
were	NULL
stimulated	NULL
with	NULL
TPO	NULL
or	NULL
SDF-1	NULL
;	NULL
p38	NULL
was	NULL
phosphorylated	NULL
by	NULL
both	NULL
TPO	NULL
and	NULL
SDF-1	NULL
,	NULL
though	NULL
the	NULL
phosphorylation	NULL
was	NULL
found	NULL
to	NULL
be	NULL
3	NULL
times	NULL
more	NULL
intense	NULL
after	NULL
stimulation	NULL
with	NULL
SDF-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
JNK	NULL
showed	NULL
no	NULL
change	NULL
in	NULL
phosphorylation	NULL
in	NULL
ap	NULL
,	NULL
fB	NULL
;	NULL
*	NULL
cells	NULL
stimulated	NULL
by	NULL
either	NULL
TPO	NULL
or	NULL
SDF-1	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AKT	NULL
is	NULL
a	NULL
serine-threonine	NULL
kinase	NULL
that	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
several	NULL
antiapoptotic	NULL
proteins	NULL
that	NULL
may	NULL
be	NULL
key	NULL
to	NULL
normal	NULL
hematopoiesis	NULL
.	NULL

*	NULL
``	NULL
~	NULL
``	NULL
It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
integrin	NULL
stimulation	NULL
of	NULL
human	NULL
ap	NULL
,	NULL
;	NULL
*	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
Figure	NULL
4	NULL
.	NULL

Adherence	NULL
of	NULL
human	NULL
cells	NULL
to	NULL
fibrinogen	NULL
.	NULL

Representative	NULL
photographs	NULL
showing	NULL
adherence	NULL
of	NULL
normal	NULL
human	NULL
«	NULL
ipB3*	NULL
cells	NULL
to	NULL
fibrinogen	NULL
.	NULL

Cells	NULL
were	NULL
not	NULL
exposed	NULL
(	NULL
A	NULL
)	NULL
or	NULL
were	NULL
exposed	NULL
(	NULL
B	NULL
)	NULL
to	NULL
SDF-1	NULL
,	NULL
TPO	NULL
(	NULL
C	NULL
)	NULL
,	NULL
SDF-1	NULL
+	NULL
TPO	NULL
(	NULL
D	NULL
)	NULL
,	NULL
thrombin	NULL
(	NULL
E	NULL
)	NULL
,	NULL
or	NULL
IL-3	NULL
(	NULL
F	NULL
)	NULL
.	NULL

Experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
in	NULL
triplicate	NULL
and	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
phospho-p44	NULL
thee	NULL
cure	NULL
phospho-p42*	NULL
y	NULL
*=	NULL
e	NULL
:	NULL
-	NULL
me	NULL
li	NULL
s	NULL
|	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Sers81	NULL
-p	NULL
»	NULL
phospho-p90	NULL
RSKS®	NULL
‘	NULL
aes	NULL
7	NULL
s	NULL
9	NULL
«	NULL
«	NULL
CBD	NULL
wo	NULL
we	NULL
am	NULL
ae	NULL
*	NULL
**	NULL
poo	NULL
nek	NULL
-	NULL
»	NULL
|	NULL
«	NULL
um	NULL
ann	NULL
dip	NULL
aap	NULL
ap	NULL
aa	NULL
aa	NULL
»	NULL
»	NULL
@	NULL
*	NULL
)	NULL
C	NULL
phospho-MAPK	NULL
30	NULL
25	NULL
+	NULL
-I	NULL
--	NULL
4	NULL
g	NULL
20	NULL
/t	NULL
~~~	NULL
]	NULL
..+*	NULL
--	NULL
TPQ	NULL
€	NULL
as	NULL
{	NULL
1	NULL
A	NULL
--	NULL
4	NULL
-a	NULL
-	NULL
SDF	NULL
E	NULL
A	NULL
£1	NULL
“	NULL
®	NULL
-	NULL
control	NULL
time	NULL
[	NULL
min	NULL
]	NULL
Figure	NULL
5	NULL
.	NULL

SDF-1	NULL
and	NULL
TPO	NULL
activate	NULL
MAPK	NULL
(	NULL
p42/44	NULL
)	NULL
and	NULL
p90	NULL
RSK	NULL
in	NULL
normal	NULL
human	NULL
oupBs*	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
MAPK	NULL
phosphorylation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
p90	NULL
RSK	NULL
(	NULL
B	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
ay5B3s*	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng/mL	NULL
.	NULL

TPO	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
or	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
10	NULL
minutes	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
30	NULL
minutes	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
an	NULL
anti-MAPK	NULL
(	NULL
p42/44	NULL
)	NULL
antibody	NULL
or	NULL
anti-p90	NULL
RSK	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Densitometric	NULL
data	NULL
showing	NULL
changes	NULL
in	NULL
MAPK	NULL
p42/44	NULL
phosphorylation	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
5	NULL
times	NULL
for	NULL
MAPK	NULL
p42/44	NULL
and	NULL
3	NULL
times	NULL
for	NULL
p90	NULL
RSK	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
from	NULL
5	NULL
independent	NULL
experiments	NULL
.	NULL

AKT	NULL
,	NULL
``	NULL
°	NULL
but	NULL
whether	NULL
TPO	NULL
stimulates	NULL
AKT	NULL
as	NULL
part	NULL
of	NULL
its	NULL
antiapoptotic	NULL
effect	NULL
and	NULL
how	NULL
this	NULL
differs	NULL
from	NULL
SDF-1	NULL
have	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

Examining	NULL
the	NULL
kinetics	NULL
of	NULL
AKT	NULL
phosphorylation	NULL
in	NULL
megakaryoblastic	NULL
cells	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
AKT	NULL
is	NULL
already	NULL
phosphorylated	NULL
1	NULL
minute	NULL
after	NULL
stimulation	NULL
by	NULL
either	NULL
TPO	NULL
or	NULL
SDF-1	NULL
;	NULL
however	NULL
,	NULL
SDF-1	NULL
phosphorylated	NULL
AKT	NULL
approximately	NULL
3	NULL
times	NULL
more	NULL
intensely	NULL
than	NULL
TPO	NULL
(	NULL
36-	NULL
+	NULL
8-	NULL
vs	NULL
10-	NULL
+	NULL
4-fold	NULL
increases	NULL
,	NULL
respec-tively	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
LY294002	NULL
abolished	NULL
SDF-1-	NULL
or	NULL
TPO-induced	NULL
AKT	NULL
phosphorylation	NULL
,	NULL
suggesting	NULL
that	NULL
AKT	NULL
phosphorylation	NULL
is	NULL
PI-3K	NULL
dependent	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
though	NULL
intracellular	NULL
signaling	NULL
through	NULL
the	NULL
c-mpl	NULL
and	NULL
the	NULL
CXCR4	NULL
receptors	NULL
overlaps	NULL
and	NULL
leads	NULL
to	NULL
phosphorylation	NULL
of	NULL
AKT	NULL
with	NULL
the	NULL
same	NULL
kinetics	NULL
,	NULL
one	NULL
results	NULL
in	NULL
an	NULL
antiapoptotic	NULL
effect	NULL
and	NULL
the	NULL
other	NULL
does	NULL
not	NULL
.	NULL

Whether	NULL
the	NULL
degree	NULL
of	NULL
phosphorylation	NULL
by	NULL
the	NULL
2	NULL
agonists	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
observed	NULL
difference	NULL
or	NULL
whether	NULL
TPO	NULL
and	NULL
SDF-1	NULL
differently	NULL
activate	NULL
other	NULL
proteins	NULL
related	NULL
to	NULL
PI-3K-AKT	NULL
axis	NULL
requires	NULL
further	NULL
analysis	NULL
.	NULL

AKT	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
B	NULL
,	NULL
a	NULL
regulator	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL
``	NULL

Because	NULL
NF-KB	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
MMP	NULL
and	NULL
and	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
above	NULL
,	NULL
the	NULL
secretion	NULL
of	NULL
both	NULL
these	NULL
factors	NULL
was	NULL
up-regulated	NULL
after	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
(	NULL
Figure	NULL
2D	NULL
,	NULL
Table	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
SDF-1	NULL
might	NULL
influence	NULL
NF-KB	NULL
activation	NULL
.	NULL

As	NULL
predicted	NULL
,	NULL
using	NULL
EMSA	NULL
,	NULL
we	NULL
detected	NULL
biologically	NULL
active	NULL
NF-KB	NULL
in	NULL
nuclear	NULL
extracts	NULL
isolated	NULL
from	NULL
normal	NULL
human	NULL
megakaryoblastic	NULL
cells	NULL
stimulated	NULL
by	NULL
SDF-1	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

At	NULL
the	NULL
same	NULL
time	NULL
,	NULL
we	NULL
established	NULL
that	NULL
TPO	NULL
did	NULL
not	NULL
SDF-1	NULL
AND	NULL
TPO	NULL
IN	NULL
MEGAKARYOPOIESIS	NULL
-	NULL
4147	NULL
influence	NULL
NF-KB	NULL
activation	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NE-	NULL
«	NULL
B	NULL
by	NULL
SDF-1	NULL
was	NULL
PI-3K	NULL
but	NULL
not	NULL
MEK	NULL
dependent	NULL
in	NULL
human	NULL
megakaryoblasts	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

SDF-1	NULL
induces	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
and	NULL
AKT	NULL
in	NULL
human	NULL
CD34+	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
platelets	NULL
We	NULL
also	NULL
investigated	NULL
the	NULL
responsiveness	NULL
of	NULL
CD34*	NULL
cells	NULL
and	NULL
circulating	NULL
platelets	NULL
to	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
or	NULL
TPO	NULL
.	NULL

Examining	NULL
CD34*	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
though	NULL
both	NULL
factors	NULL
induced	NULL
the	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
and	NULL
AKT	NULL
(	NULL
Figure	NULL
8A¥	NULL
,	NULL
B	NULL
)	NULL
,	NULL
only	NULL
TPO	NULL
stimulated	NULL
the	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
and	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
,	NULL
protected	NULL
them	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
.	NULL
``	NULL

This	NULL
observation	NULL
again	NULL
suggests	NULL
that	NULL
SDF-1	NULL
is	NULL
not	NULL
primarily	NULL
directed	NULL
toward	NULL
maintaining	NULL
or	NULL
enhancing	NULL
cell	NULL
proliferation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CD34*	NULL
and	NULL
ap	NULL
,	NULL
Bs*	NULL
cells	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
platelets	NULL
by	NULL
SDF-1	NULL
under	NULL
similar	NULL
conditions	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
and	NULL
AKT	NULL
(	NULL
Figure	NULL
9A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
supports	NULL
our	NULL
hypothesis	NULL
that	NULL
the	NULL
responsiveness	NULL
of	NULL
CXCR4	NULL
to	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
(	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
phospho	NULL
Ap	NULL
TBerd73	NULL
-le	NULL
]	NULL
-	NULL
-	NULL
*=	NULL
@	NULL
see	NULL
<	NULL
+	NULL
*	NULL
AKT	NULL
*	NULL
)	NULL
on	NULL
<	NULL
»	NULL
tires	NULL
cn	NULL
B	NULL
phospho-AKT	NULL
50	NULL
3	NULL
iz	NULL
g	NULL
**	NULL
i	NULL
‘	NULL
Tro	NULL
©	NULL
30	NULL
44	NULL
's	NULL
.	NULL

|	NULL
rcs®es	NULL
's	NULL
5	NULL
f	NULL
*	NULL
--	NULL
m	NULL
--	NULL
SDF	NULL
€	NULL
20	NULL
1	NULL
x	NULL
|	NULL
3	NULL
a	NULL
>	NULL
®	NULL
_	NULL
control	NULL
2	NULL
10	NULL
4	NULL
I	NULL
;	NULL
0	NULL
~*	NULL
0	NULL
1	NULL
10	NULL
30°	NULL
60	NULL
'	NULL
time	NULL
[	NULL
min	NULL
]	NULL
C	NULL
u	NULL
-	NULL
TPO	NULL
TPO	NULL
LY294002	NULL
DNTSO	NULL
1	NULL
mol/l	NULL
.	NULL

-	NULL
10	NULL
imoUl	NULL
-	NULL
30	NULL
moll	NULL
Phospho-AKT	NULL
-	NULL
&	NULL
»	NULL
acim	NULL
1	NULL
31	NULL
35	NULL
30	NULL
12	NULL
1.9	NULL
ait	NULL
-+	NULL
|	NULL
upp	NULL
rr	NULL
apraear	NULL
essas	NULL
»	NULL
Figure	NULL
6	NULL
.	NULL

SDF-1	NULL
and	NULL
TPO	NULL
phosphorylate	NULL
AKT	NULL
in	NULL
normal	NULL
human	NULL
cells	NULL
in	NULL
a	NULL
PI-3K-dependent	NULL
manner	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
AKT	NULL
phosphorylation	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
«	NULL
i	NULL
,	NULL
B3*®	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
or	NULL
500	NULL
ng/mL	NULL
of	NULL
SDF-1	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
10	NULL
minutes	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
30	NULL
minutes	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
an	NULL
anti-AKT	NULL
antibody	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Densitometric	NULL
data	NULL
showing	NULL
changes	NULL
in	NULL
AKT	NULL
phosphorylation	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
5	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Data	NULL
are	NULL
presented	NULL
from	NULL
5	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Normal	NULL
human	NULL
aiB3*	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
LY294002	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TPO	NULL
(	NULL
100	NULL
ng/mL	NULL
)	NULL
or	NULL
SDF-1	NULL
(	NULL
500	NULL
ng/mL	NULL
)	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

phospho-AKT	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
;	NULL
total	NULL
AKT	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4148	NULL
_	NULL
MAJKAetal	NULL
A	NULL
_	NULL
SDF	NULL
TPO	NULL
30	NULL
-	NULL
60	NULL
420	NULL
(	NULL
)	NULL
30	NULL
=	NULL
60	NULL
120	NULL
min	NULL
min	NULL
min	NULL
min	NULL
min	NULL
min	NULL
___	NULL
<	NULL
4	NULL
NF-cB	NULL
B	NULL
__VU0126	NULL
___	NULL
_LY	NULL
294002	NULL
_	NULL
10	NULL
30	NULL
10	NULL
30	NULL
_	NULL
(	NULL
)	NULL
-	NULL
SDF-mol/L	NULL
mol/L	NULL
mol/L	NULL
umol/L	NULL
.	NULL

mao	NULL
most	NULL
Hat	NULL
met	NULL
wos	NULL
Hie	NULL
<	NULL
--	NULL
NFB	NULL
iim	NULL
Figure	NULL
7	NULL
.	NULL

SDF-1	NULL
,	NULL
but	NULL
not	NULL
TPO	NULL
,	NULL
stimulates	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
human	NULL
ep	NULL
$	NULL
B3s*	NULL
cells	NULL
in	NULL
a	NULL
PI-3K-dependent	NULL
manner	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Normal	NULL
human	NULL
cells	NULL
were	NULL
made	NULL
quiescent	NULL
and	NULL
subsequently	NULL
were	NULL
stimulated	NULL
with	NULL
300	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
)	NULL
or	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
cell	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
for	NULL
30	NULL
minutes	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
60	NULL
minutes	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
120	NULL
minutes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
nonstimulated	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
TPO	NULL
for	NULL
30	NULL
minutes	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
60	NULL
minutes	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
120	NULL
minutes	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
autoradiogram	NULL
of	NULL
2	NULL
separate	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Normal	NULL
human	NULL
«	NULL
1463+	NULL
cells	NULL
were	NULL
made	NULL
quiescent	NULL
and	NULL
then	NULL
were	NULL
pretreated	NULL
with	NULL
10	NULL
mol/L	NULL
or	NULL
30	NULL
pmol/L	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
MEK	NULL
inhibitor	NULL
UO126	NULL
or	NULL
10	NULL
wmol/L	NULL
or	NULL
30	NULL
mol/L	NULL
PI-3K	NULL
inhibitor	NULL
LY294002	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
300	NULL
ng/mL	NULL
SDF-1	NULL
.	NULL

Control	NULL
,	NULL
cells	NULL
pretreated	NULL
but	NULL
not	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
cells	NULL
not	NULL
pretreated	NULL
but	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
SDF-1	NULL
for	NULL
90	NULL
minutes	NULL
.	NULL

A	NULL
representative	NULL
autoradiogram	NULL
of	NULL
2	NULL
separate	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

p42/44	NULL
,	NULL
and	NULL
AKT	NULL
)	NULL
decreases	NULL
in	NULL
the	NULL
final	NULL
stages	NULL
of	NULL
megakaryocyto-poiesis-thrombocytopoiesis	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TPO	NULL
stimulation	NULL
of	NULL
human	NULL
platelets	NULL
resulted	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42	NULL
and	NULL
AKT	NULL
(	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
family	NULL
proteins	NULL
in	NULL
human	NULL
megakaryoblasts	NULL
Despite	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
op	NULL
,	NULL
fB3*	NULL
cells	NULL
with	NULL
SDF-1	NULL
led	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
,	NULL
p38	NULL
and	NULL
the	NULL
nuclear	NULL
protein	NULL
ELK-1	NULL
,	NULL
SDF-1	NULL
(	NULL
as	NULL
shown	NULL
above	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
proliferation	NULL
or	NULL
maturation	NULL
of	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
looked	NULL
at	NULL
BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
p44	NULL
_	NULL
&	NULL
phOS	NULL
phO-	NULL
p42-	NULL
*~	NULL
i-	NULL
»	NULL
[	NULL
«	NULL
as	NULL
a	NULL
|	NULL
B	NULL
1	NULL
2	NULL
_	NULL
3	NULL
phospho-AKT	NULL
-	NULL
»	NULL
El	NULL
C	NULL
1	NULL
2	NULL
3	NULL
phospho-STAT	NULL
5	NULL
-	NULL
»	NULL
E	NULL
STAT	NULL
5	NULL
@	NULL
-=-|	NULL
«	NULL
«	NULL
-	NULL
«	NULL
»	NULL
«	NULL
|	NULL
Figure	NULL
8	NULL
.	NULL

Phosphorylation	NULL
studies	NULL
of	NULL
CD34+	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
MAPK	NULL
p42/44	NULL
phosphorylation	NULL
(	NULL
A	NULL
)	NULL
,	NULL
AKT	NULL
phosphorylation	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
STAT-5	NULL
phosphorylation	NULL
(	NULL
C	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
CD34*	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
10	NULL
minutes	NULL
by	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
for	NULL
1	NULL
minute	NULL
by	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
anti-MAPK	NULL
p42/44	NULL
,	NULL
AKT	NULL
,	NULL
and	NULL
STAT-5	NULL
antibodies	NULL
(	NULL
lower	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

the	NULL
activation	NULL
of	NULL
the	NULL
JAK-STAT	NULL
pathways	NULL
in	NULL
normal	NULL
human	NULL
on	NULL
,	NULL
B3*	NULL
cells	NULL
.	NULL

STAT	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
cell	NULL
and	NULL
in	NULL
signaling	NULL
from	NULL
the	NULL
activated	NULL
c-mpl	NULL
receptor	NULL
in	NULL
various	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
``	NULL
``	NULL
and	NULL
normal	NULL
human	NULL
platelets	NULL
.	NULL

``	NULL
>	NULL
``	NULL
``	NULL
In	NULL
particular	NULL
,	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
platelets	NULL
by	NULL
TPO	NULL
led	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT-1	NULL
,	NULL
STAT-2	NULL
,	NULL
STAT-3	NULL
,	NULL
and	NULL
STAT-5	NULL
proteins	NULL
``	NULL
``	NULL
and	NULL
of	NULL
STAT-3	NULL
and	NULL
STAT-5	NULL
in	NULL
FDCP-2	NULL
cells	NULL
genetically	NULL
engineered	NULL
to	NULL
constitutively	NULL
express	NULL
human	NULL
c-mpl	NULL
.	NULL

*	NULL
``	NULL
However	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
SDF-1	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
studied	NULL
.	NULL

We	NULL
focused	NULL
our	NULL
studies	NULL
on	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT-1	NULL
and	NULL
STAT-3	NULL
at	NULL
both	NULL
Tyr705	NULL
and	NULL
Ser727	NULL
and	NULL
of	NULL
STAT-5	NULL
and	NULL
STAT-6	NULL
(	NULL
Figures	NULL
10	NULL
,	NULL
11	NULL
)	NULL
in	NULL
human	NULL
megakaryocytes	NULL
,	NULL
and	NULL
we	NULL
found	NULL
that	NULL
among	NULL
these	NULL
proteins	NULL
,	NULL
only	NULL
STAT-3	NULL
at	NULL
Ser727	NULL
was	NULL
phosphorylated	NULL
A	NULL
1	NULL
2	NULL
_3	NULL
C	NULL
3	NULL
.	NULL

3	NULL
phospho-p42	NULL
-	NULL
#	NULL
El	NULL
phospho-STAT	NULL
3	NULL
-	NULL
-	NULL
#	NULL
m-	NULL
--	NULL
-	NULL
B	NULL
1__2	NULL
_3	NULL
D	NULL
1	NULL
3	NULL
phospho-AKT	NULL
_	NULL
-	NULL
#	NULL
E	NULL
phospho-STAT	NULL
5	NULL
-	NULL
-	NULL
#	NULL
-	NULL
+~==	NULL
)	NULL
Figure	NULL
9	NULL
.	NULL

SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
phosphorylate	NULL
MAPK	NULL
,	NULL
AKT	NULL
,	NULL
and	NULL
STAT	NULL
proteins	NULL
in	NULL
human	NULL
platelets	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
MAPK	NULL
p42/44	NULL
phosphorylation	NULL
(	NULL
A	NULL
)	NULL
,	NULL
AKT	NULL
phosphorylation	NULL
(	NULL
B	NULL
)	NULL
,	NULL
STAT-3	NULL
(	NULL
Tyr	NULL
705	NULL
)	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
STAT-5	NULL
(	NULL
D	NULL
)	NULL
phosphorylation	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
platelets	NULL
.	NULL

Platelets	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
10	NULL
minutes	NULL
by	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
for	NULL
1	NULL
minute	NULL
by	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
anti-MAPK	NULL
p42/44	NULL
,	NULL
AKT	NULL
,	NULL
and	NULL
STAT-5	NULL
antibodies	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
68	NULL
7	NULL
8	NULL
3	NULL
phospho-STAT	NULL
1	NULL
Tyr7z05	NULL
ﬂ	NULL
Cik	NULL
=	NULL
i	NULL
%	NULL
=	NULL
--	NULL
I	NULL
STAT1—P	NULL
‘	NULL
..	NULL
,	NULL
_	NULL
,	NULL
,	NULL
_	NULL
,	NULL
__..___	NULL
,	NULL
_|	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
phospho-STAT	NULL
-	NULL
-	NULL
»	NULL
]	NULL
me	NULL
C	NULL
w	NULL
©	NULL
ae	NULL
=	NULL
-	NULL
|	NULL
stat	NULL
5	NULL
}	NULL
P|	NULL
mI	NULL
=	NULL
>	NULL
=rur	NULL
u	NULL
@	NULL
eres	NULL
C	NULL
1	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
phospho-STAT	NULL
6Tyr641	NULL
A	NULL
#	NULL
4	NULL
Figure	NULL
10	NULL
.	NULL

SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
phosphorylate	NULL
STAT-1	NULL
,	NULL
STAT-5	NULL
,	NULL
or	NULL
STAT-6	NULL
in	NULL
normal	NULL
human	NULL
aneBzs*	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
STAT-1	NULL
phosphorylation	NULL
(	NULL
A	NULL
)	NULL
,	NULL
STAT-5	NULL
phosphorylation	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
STAT-6	NULL
phosphorylation	NULL
(	NULL
C	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
ay5B3s*	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
or	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,10	NULL
minutes	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
30	NULL
minutes	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
an	NULL
anti-STAT-1	NULL
,	NULL
anti-STAT-5	NULL
,	NULL
or	NULL
anti-STAT-6	NULL
antibody	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

after	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
(	NULL
Figure	NULL
11B	NULL
)	NULL
.	NULL

TPO	NULL
,	NULL
however	NULL
,	NULL
caused	NULL
phosphorylation	NULL
of	NULL
all	NULL
the	NULL
STAT	NULL
proteins	NULL
tested	NULL
(	NULL
Figures	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
of	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
was	NULL
maximal	NULL
10	NULL
minutes	NULL
after	NULL
stimulation	NULL
by	NULL
TPO	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
multiple	NULL
STAT	NULL
proteins	NULL
were	NULL
not	NULL
phosphorylated	NULL
in	NULL
cells	NULL
after	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
may	NULL
provide	NULL
a	NULL
molecular	NULL
explanation	NULL
as	NULL
to	NULL
why	NULL
SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
proliferation	NULL
of	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

SDF-1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TPO	NULL
,	NULL
does	NULL
not	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
human	NULL
CD34+	NULL
cells	NULL
and	NULL
platelets	NULL
Finally	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
responsiveness	NULL
of	NULL
both	NULL
human	NULL
CD34*	NULL
cells	NULL
and	NULL
circulating	NULL
platelets	NULL
to	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
or	NULL
TPO	NULL
.	NULL

We	NULL
found	NULL
that	NULL
only	NULL
TPO	NULL
stimulated	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT-5	NULL
(	NULL
Figures	NULL
8C	NULL
,	NULL
9D	NULL
)	NULL
and	NULL
STAT-3	NULL
at	NULL
Tyr705	NULL
(	NULL
Figure	NULL
9C	NULL
)	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
for	NULL
human	NULL
CD34*	NULL
cells	NULL
(	NULL
Figure	NULL
8C	NULL
)	NULL
may	NULL
also	NULL
explain	NULL
why	NULL
TPO	NULL
,	NULL
but	NULL
not	NULL
SDF-1	NULL
,	NULL
stimulates	NULL
the	NULL
proliferation	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
.	NULL

Discussion	NULL
Data	NULL
on	NULL
CXCR4	NULL
or	NULL
SDF-1	NULL
knockout	NULL
mice	NULL
``	NULL
and	NULL
recent	NULL
findings	NULL
suggesting	NULL
that	NULL
SDF-1	NULL
enhances	NULL
the	NULL
effect	NULL
of	NULL
TPO®	NULL
'	NULL
``	NULL
on	NULL
megakaryocyte	NULL
formation	NULL
indicate	NULL
a	NULL
potential	NULL
role	NULL
for	NULL
SDF-1	NULL
in	NULL
megakaryopoiesis	NULL
.	NULL

However	NULL
,	NULL
our	NULL
previous	NULL
work	NULL
``	NULL
``	NULL
and	NULL
that	NULL
of	NULL
others	NULL
``	NULL
provided	NULL
evidence	NULL
that	NULL
though	NULL
SDF-1	NULL
stimulated	NULL
homing	NULL
features	NULL
in	NULL
human	NULL
megakaryocytic	NULL
progenitors	NULL
,	NULL
it	NULL
did	NULL
not	NULL
influence	NULL
CFU-MK	NULL
formation	NULL
and	NULL
growth	NULL
.	NULL

These	NULL
observations	NULL
prompted	NULL
us	NULL
to	NULL
compare	NULL
the	NULL
effects	NULL
of	NULL
SDF-1	NULL
with	NULL
those	NULL
of	NULL
TPO	NULL
on	NULL
development	NULL
and	NULL
activation	NULL
of	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
and	NULL
to	NULL
study	NULL
the	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
activated	NULL
by	NULL
these	NULL
cytokines	NULL
to	NULL
better	NULL
define	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
observed	NULL
differences	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
CD34	NULL
*	NULL
cells	NULL
and	NULL
megakaryoblasts	NULL
by	NULL
SDF-1	NULL
does	NULL
not	NULL
influence	NULL
proliferation	NULL
,	NULL
apoptosis	NULL
,	NULL
or	NULL
telomerase	NULL
activity	NULL
,	NULL
even	NULL
when	NULL
the	NULL
SDF-1	NULL
is	NULL
added	NULL
with	NULL
TPO	NULL
.	NULL

Hence	NULL
,	NULL
our	NULL
data	NULL
collectively	NULL
suggest	NULL
that	NULL
,	NULL
unlike	NULL
TPO	NULL
,	NULL
SDF-1	NULL
is	NULL
not	NULL
a	NULL
megakaryopoi-	NULL
SDF-1	NULL
AND	NULL
TPO	NULL
IN	NULL
MEGAKARYOPOIESIS	NULL
-	NULL
4149	NULL
etic	NULL
growth	NULL
factor	NULL
.	NULL

This	NULL
agrees	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
demonstrating	NULL
lack	NULL
of	NULL
a	NULL
proliferative	NULL
effect	NULL
by	NULL
SDF-1	NULL
on	NULL
CFU-MK	NULL
formation	NULL
from	NULL
human	NULL
CD34+*	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
it	NULL
does	NULL
not	NULL
support	NULL
recent	NULL
observations	NULL
on	NULL
a	NULL
murine	NULL
model	NULL
suggesting	NULL
that	NULL
SDF-1	NULL
acts	NULL
together	NULL
with	NULL
TPO	NULL
to	NULL
enhance	NULL
the	NULL
development	NULL
of	NULL
CFU-MK	NULL
``	NULL
and	NULL
that	NULL
SDF-1	NULL
at	NULL
low	NULL
doses	NULL
enhances	NULL
the	NULL
proliferation	NULL
of	NULL
peripheral	NULL
blood	NULL
CD34	NULL
*	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
suggest	NULL
that	NULL
this	NULL
difference	NULL
in	NULL
results	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
different	NULL
culture	NULL
systems	NULL
used	NULL
(	NULL
serum-free	NULL
medium	NULL
vs	NULL
serum-supplemented	NULL
medium	NULL
)	NULL
or	NULL
to	NULL
the	NULL
different	NULL
target	NULL
cells	NULL
(	NULL
human	NULL
vs	NULL
murine	NULL
marrow	NULL
cells	NULL
)	NULL
.	NULL

We	NULL
next	NULL
evaluated	NULL
the	NULL
role	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
in	NULL
the	NULL
homing	NULL
of	NULL
human	NULL
megakaryoblastic	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
TPO	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
SDF-1	NULL
,	NULL
does	NULL
not	NULL
induce	NULL
Ca+**	NULL
flux	NULL
and	NULL
is	NULL
not	NULL
a	NULL
chemoattractant	NULL
for	NULL
human	NULL
op	NULL
,	NULL
*	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
human	NULL
megakaryoblasts	NULL
secrete	NULL
MMP-9	NULL
constitutively	NULL
and	NULL
that	NULL
SDF-1	NULL
slightly	NULL
up-regulates	NULL
it	NULL
.	NULL

Moreover	NULL
,	NULL
trans-	NULL
Matrigel	NULL
chemotaxis	NULL
of	NULL
megakaryoblasts	NULL
to	NULL
an	NULL
SDF-1	NULL
gradient	NULL
was	NULL
decreased	NULL
by	NULL
the	NULL
tissue	NULL
inhibitors	NULL
of	NULL
MMPs	NULL
rhTIMP-1	NULL
and	NULL
rhTIMP-2	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
by	NULL
SDF-1	NULL
,	NULL
but	NULL
not	NULL
by	NULL
TPO	NULL
,	NULL
increases	NULL
endogenous	NULL
secretion	NULL
of	NULL
VEGF	NULL
by	NULL
these	NULL
cells	NULL
.	NULL

Because	NULL
VEGF	NULL
up-regulates	NULL
the	NULL
expression	NULL
of	NULL
E-selectin	NULL
on	NULL
human	NULL
endothelium	NULL
,	NULL
``	NULL
``	NULL
we	NULL
postulate	NULL
that	NULL
VEGF	NULL
endogenously	NULL
secreted	NULL
by	NULL
megakaryocytic	NULL
cells	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
interaction	NULL
of	NULL
megakaryocytes	NULL
with	NULL
endothelium	NULL
,	NULL
``	NULL
``	NULL
``	NULL
°	NULL
their	NULL
egress	NULL
from	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
and	NULL
proplatelet	NULL
formation	NULL
.	NULL
'	NULL

''	NULL
Adhesion	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
to	NULL
fibrinogen	NULL
and	NULL
vitronectin	NULL
was	NULL
also	NULL
increased	NULL
by	NULL
SDF-1	NULL
,	NULL
and	NULL
both	NULL
agonists	NULL
were	NULL
synergistic	NULL
in	NULL
activating	NULL
binding	NULL
of	NULL
the	NULL
latter	NULL
.	NULL

This	NULL
supports	NULL
the	NULL
hypothesis	NULL
that	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
may	NULL
regulate	NULL
the	NULL
adhesiveness	NULL
of	NULL
megakaryoblasts	NULL
in	NULL
the	NULL
hematopoietic	NULL
microenvironment	NULL
by	NULL
activating	NULL
op	NULL
,	NULL
;	NULL
and	NULL
«	NULL
yfBs	NULL
integrins	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
also	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
showing	NULL
that	NULL
SDF-1	NULL
activates	NULL
integrins	NULL
(	NULL
«	NULL
,	NULL
B	NULL
;	NULL
and	NULL
o4	NULL
B	NULL
;	NULL
)	NULL
on	NULL
the	NULL
surfaces	NULL
of	NULL
human	NULL
CD34*	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
Collectively	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
homing	NULL
of	NULL
immature	NULL
megakaryoblasts	NULL
in	NULL
bone	NULL
marrow	NULL
and	NULL
egress	NULL
of	NULL
platelet-releasing	NULL
megakaryocytes	NULL
through	NULL
the	NULL
endothelial	NULL
layer	NULL
and	NULL
suben-dothelial	NULL
basement	NULL
membranes	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
changes	NULL
in	NULL
or	NULL
responsiveness	NULL
to	NULL
an	NULL
SDF-1	NULL
gradient	NULL
.	NULL
``	NULL

To	NULL
find	NULL
an	NULL
explanation	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
biologic	NULL
effects	NULL
of	NULL
SDF-1	NULL
and	NULL
TPO	NULL
,	NULL
we	NULL
investigated	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
by	NULL
these	NULL
cytokines	NULL
.	NULL

First	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
human	NULL
oun	NULL
,	NULL
B3	NULL
*	NULL
cells	NULL
by	NULL
both	NULL
TPO	NULL
and	NULL
SDF-1	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
kinases	NULL
MAPK	NULL
p42/44	NULL
and	NULL
p38	NULL
and	NULL
their	NULL
downstream	NULL
targets	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
phospho-STAT	NULL
3791705	NULL
-	NULL
»	NULL
>	NULL
|	NULL
&	NULL
&	NULL
w	NULL
_|	NULL
STAT	NULL
3	NULL
—	NULL
>	NULL
|	NULL
Ml	NULL
B	NULL
1	NULL
__	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
$	NULL
3	NULL
phospho—STAT	NULL
3Ser	NULL
?	NULL

2	NULL
?	NULL

—pt	NULL
«	NULL
--	NULL
«	NULL
o	NULL
din	NULL
dge	NULL
can	NULL
wgn	NULL
cam	NULL
wa	NULL
|	NULL
stat	NULL
;	NULL
>	NULL
|	NULL
<	NULL
a	NULL
as	NULL
as	NULL
an	NULL
as	NULL
as	NULL
an	NULL
an	NULL
as	NULL
|	NULL
Figure	NULL
11	NULL
.	NULL

SDF-1	NULL
phosphorylates	NULL
STAT-3	NULL
at	NULL
Ser727	NULL
but	NULL
not	NULL
at	NULL
Tyr705	NULL
in	NULL
ougB3s*	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
STAT-3	NULL
phosphorylation	NULL
at	NULL
Tyr705	NULL
(	NULL
A	NULL
)	NULL
and	NULL
at	NULL
Ser727	NULL
(	NULL
B	NULL
)	NULL
in	NULL
normal	NULL
human	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
nonstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng/mL	NULL
TPO	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
or	NULL
500	NULL
ng/mL	NULL
SDF-1	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
for	NULL
1	NULL
minute	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
10	NULL
minutes	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
30	NULL
minutes	NULL
(	NULL
lanes	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
1	NULL
hour	NULL
(	NULL
lanes	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Equal	NULL
loading	NULL
in	NULL
the	NULL
lanes	NULL
was	NULL
evaluated	NULL
by	NULL
stripping	NULL
the	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
an	NULL
anti-STAT-3	NULL
antibody	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

4150	NULL
_	NULL
MAJKA	NULL
etal	NULL
(	NULL
p90	NULL
RSK	NULL
and	NULL
ELK-1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
a	NULL
clear	NULL
difference	NULL
in	NULL
the	NULL
kinetics	NULL
and	NULL
possibly	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
stimulation	NULL
of	NULL
megakaryoblasts	NULL
by	NULL
these	NULL
2	NULL
cytokines	NULL
.	NULL

This	NULL
may	NULL
be	NULL
related	NULL
to	NULL
previous	NULL
observations	NULL
that	NULL
signaling	NULL
pathways	NULL
from	NULL
G-protein-coupled	NULL
CXCR	NULL
receptors	NULL
are	NULL
activated	NULL
faster	NULL
``	NULL
*	NULL
``	NULL
*	NULL
than	NULL
those	NULL
from	NULL
the	NULL
cytokine-type	NULL
c-mpl	NULL
receptor	NULL
.	NULL

!	NULL

AKT	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
important	NULL
in	NULL
preventing	NULL
apoptosis	NULL
during	NULL
hematopoiesis	NULL
.	NULL
``	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
have	NULL
now	NULL
demonstrated	NULL
that	NULL
AKT	NULL
is	NULL
phosphorylated	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
after	NULL
stimulation	NULL
by	NULL
both	NULL
SDF-1	NULL
and	NULL
TPO	NULL
in	NULL
a	NULL
PI-3K-dependent	NULL
manner	NULL
and	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
PI-3K	NULL
activity	NULL
by	NULL
LY294002	NULL
induced	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
though	NULL
both	NULL
factors	NULL
activate	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
,	NULL
our	NULL
in	NULL
vitro	NULL
data	NULL
showed	NULL
that	NULL
only	NULL
TPO	NULL
protected	NULL
cells	NULL
from	NULL
apoptosis	NULL
;	NULL
SDF-1	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
their	NULL
survival	NULL
.	NULL

We	NULL
therefore	NULL
postulate	NULL
that	NULL
SDF-1-driven	NULL
activation	NULL
of	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
appropriate	NULL
antiapoptotic	NULL
pathways	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
TPO	NULL
and	NULL
SDF-1	NULL
differentially	NULL
activate	NULL
other	NULL
proteins	NULL
related	NULL
to	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
.	NULL

A	NULL
report	NULL
showing	NULL
that	NULL
activation	NULL
of	NULL
AKT	NULL
does	NULL
not	NULL
always	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
inactivation	NULL
of	NULL
proapoptotic	NULL
BAD	NULL
supports	NULL
this	NULL
hypothesis	NULL
.	NULL
``	NULL

Based	NULL
on	NULL
these	NULL
results	NULL
,	NULL
we	NULL
postulate	NULL
the	NULL
simultaneous	NULL
activation	NULL
of	NULL
other	NULL
pathways	NULL
by	NULL
TPO	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
that	NULL
are	NULL
central	NULL
to	NULL
preventing	NULL
apoptosis	NULL
of	NULL
*	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
investigating	NULL
this	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
found	NULL
that	NULL
NF-kB	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
the	NULL
PI-3K-AKT	NULL
axis	NULL
downstream-regulated	NULL
proteins	NULL
,	NULL
is	NULL
activated	NULL
after	NULL
stimulation	NULL
by	NULL
SDF-1	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
NF-kB	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
MMP-9°°	NULL
and	NULL
VEGF	NULL
explains	NULL
why	NULL
the	NULL
stimulation	NULL
of	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
by	NULL
SDF-1	NULL
leads	NULL
to	NULL
increased	NULL
endogenous	NULL
MMP-9	NULL
and	NULL
VEGF	NULL
secretion	NULL
.	NULL

Because	NULL
TPO	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
developing	NULL
murine	NULL
megakaryocytes	NULL
through	NULL
JAK-STAT	NULL
pathways	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
we	NULL
investigated	NULL
whether	NULL
similar	NULL
pathways	NULL
are	NULL
activated	NULL
after	NULL
SDF-1	NULL
stimulation	NULL
.	NULL

Identification	NULL
of	NULL
these	NULL
pathways	NULL
could	NULL
shed	NULL
more	NULL
light	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
proliferation	NULL
of	NULL
normal	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
and	NULL
explain	NULL
at	NULL
a	NULL
molecular	NULL
level	NULL
why	NULL
TPO	NULL
and	NULL
not	NULL
SDF-1	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
this	NULL
study	NULL
,	NULL
stimulated	NULL
the	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
only	NULL
BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
STAT-3	NULL
was	NULL
phosphorylated	NULL
at	NULL
the	NULL
serine	NULL
residue	NULL
(	NULL
Ser727	NULL
)	NULL
after	NULL
SDF-1	NULL
stimulation	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
much	NULL
of	NULL
the	NULL
STAT	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
are	NULL
phosphorylated	NULL
by	NULL
TPO	NULL
at	NULL
tyrosine	NULL
residues	NULL
in	NULL
megakaryocytic	NULL
cells	NULL
.	NULL
``	NULL

Because	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
at	NULL
Ser727	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
STAT-3	NULL
protein	NULL
activation	NULL
,	NULL
``	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT-3	NULL
at	NULL
Ser727	NULL
by	NULL
SDF-1	NULL
suggests	NULL
that	NULL
it	NULL
may	NULL
down-regulate	NULL
STAT-3	NULL
in	NULL
normal	NULL
human	NULL
megakaryoblasts	NULL
.	NULL

Hence	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK-STAT	NULL
proteins	NULL
probably	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
proliferation	NULL
of	NULL
megakaryocytic	NULL
cells	NULL
after	NULL
TPO	NULL
stimulation	NULL
but	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
p42/44	NULL
and	NULL
p38	NULL
pathways	NULL
is	NULL
not	NULL
an	NULL
important	NULL
intermediate	NULL
step	NULL
in	NULL
the	NULL
proliferation	NULL
of	NULL
these	NULL
cells	NULL
given	NULL
that	NULL
SDF-1	NULL
also	NULL
activates	NULL
them	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
MEK	NULL
by	NULL
UO126	NULL
affected	NULL
neither	NULL
survival	NULL
nor	NULL
proliferation	NULL
of	NULL
human	NULL
megakaryoblasts	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
recent	NULL
studies	NULL
showing	NULL
that	NULL
the	NULL
MAPK	NULL
p42/44	NULL
pathway	NULL
is	NULL
not	NULL
required	NULL
for	NULL
megakaryoblast	NULL
formation	NULL
,	NULL
though	NULL
it	NULL
may	NULL
regulate	NULL
the	NULL
transition	NULL
from	NULL
proliferation	NULL
to	NULL
maturation	NULL
in	NULL
this	NULL
lineage	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
MAPK	NULL
p42/44	NULL
,	NULL
p38	NULL
,	NULL
and	NULL
AKT	NULL
after	NULL
stimulation	NULL
with	NULL
SDF-1	NULL
does	NULL
not	NULL
occur	NULL
in	NULL
human	NULL
platelets	NULL
,	NULL
and	NULL
we	NULL
find	NULL
this	NULL
intriguing	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
the	NULL
differences	NULL
between	NULL
human	NULL
megakaryoblasts	NULL
and	NULL
platelets	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
G	NULL
and	NULL
RGS	NULL
proteins	NULL
,	NULL
coupled	NULL
to	NULL
the	NULL
particular	NULL
chemokine	NULL
receptor	NULL
,	NULL
could	NULL
explain	NULL
these	NULL
differences	NULL
.	NULL
``	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
though	NULL
both	NULL
TPO	NULL
and	NULL
SDF-1	NULL
are	NULL
important	NULL
in	NULL
megakaryopoiesis	NULL
and	NULL
stimulate	NULL
some	NULL
of	NULL
the	NULL
same	NULL
intracellular	NULL
pathways	NULL
,	NULL
they	NULL
have	NULL
distinct	NULL
biologic	NULL
effects	NULL
on	NULL
human	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

SDF-1	NULL
,	NULL
but	NULL
not	NULL
TPO	NULL
,	NULL
regulates	NULL
some	NULL
steps	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
the	NULL
hematopoietic	NULL
microenvironment	NULL
(	NULL
eg	NULL
,	NULL
chemotaxis	NULL
and	NULL
secretion	NULL
of	NULL
MMP-9	NULL
and	NULL
VEGF	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TPO	NULL
,	NULL
but	NULL
not	NULL
SDF-1	NULL
,	NULL
permits	NULL
growth	NULL
of	NULL
megakaryocyte	NULL
precursors	NULL
(	NULL
eg	NULL
,	NULL
by	NULL
enhancing	NULL
proliferation	NULL
and	NULL
by	NULL
inhibiting	NULL
apoptosis	NULL
)	NULL
;	NULL
both	NULL
factors	NULL
regulate	NULL
their	NULL
adhesion	NULL
.	NULL

Hence	NULL
,	NULL
this	NULL
study	NULL
sheds	NULL
light	NULL
on	NULL
the	NULL
relation	NULL
between	NULL
2	NULL
distinct	NULL
cytokine	NULL
axes	NULL
critical	NULL
in	NULL
human	NULL
megakaryopoiesis	NULL
and	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
cellular	NULL
responses	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kaushansky	NULL
K.	NULL
Thrombopoietin	NULL
:	NULL
the	NULL
primary	NULL
8	NULL
.	NULL

Ji	NULL
TH	NULL
,	NULL
Grossmann	NULL
M	NULL
,	NULL
Ji	NULL
J.	NULL
G	NULL
protein-coupled	NULL
re-	NULL
14	NULL
.	NULL

Mohle	NULL
R	NULL
,	NULL
Bautz	NULL
F	NULL
,	NULL
Rafii	NULL
S	NULL
,	NULL
Moore	NULL
MA	NULL
,	NULL
Brugger	NULL
W	NULL
,	NULL
regulator	NULL
of	NULL
platelet	NULL
production	NULL
.	NULL

Blood	NULL
.	NULL

1995	NULL
;	NULL
86	NULL
:	NULL
ceptors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273:17299-17302	NULL
.	NULL

Kanz	NULL
L.	NULL
The	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
is	NULL
ex-419-431	NULL
.	NULL

9	NULL
.	NULL

Wang	NULL
JF	NULL
,	NULL
Liu	NULL
ZY	NULL
,	NULL
Groopman	NULL
JE	NULL
.	NULL

The	NULL
B-chemo-	NULL
pressed	NULL
on	NULL
CD34	NULL
+	NULL
hematopoietic	NULL
progenitors	NULL
2	NULL
.	NULL

Debili	NULL
N	NULL
,	NULL
Wendling	NULL
F	NULL
,	NULL
Cosman	NULL
D	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
mpl	NULL
receptor	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
from	NULL
late	NULL
progenitors	NULL
to	NULL
platelets	NULL
.	NULL

Blood	NULL
.	NULL

1995	NULL
;	NULL
85:391-401	NULL
.	NULL

3	NULL
.	NULL

Nagasawa	NULL
T	NULL
,	NULL
Hirota	NULL
S	NULL
,	NULL
Tachibana	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Defects	NULL
10.	NULL
of	NULL
B-cell	NULL
lymphopoiesis	NULL
and	NULL
bone-marrow	NULL
myelo-poiesis	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
CXC	NULL
chemokine	NULL
PBSE/SDF-1	NULL
.	NULL

Nature	NULL
.	NULL

1996	NULL
;	NULL
382:635-638	NULL
.	NULL

4	NULL
.	NULL

Zou	NULL
Y	NULL
,	NULL
Kottman	NULL
AH	NULL
,	NULL
Kuroda	NULL
M	NULL
,	NULL
Taniuchi	NULL
I	NULL
,	NULL
Littman	NULL
DR.	NULL
Function	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CXCR4	NULL
in	NULL
haematopoiesis	NULL
and	NULL
in	NULL
cerebellar	NULL
develop-ment	NULL
.	NULL

Nature	NULL
.	NULL

1998	NULL
;	NULL
393:595-599	NULL
.	NULL

5	NULL
.	NULL

Blalock	NULL
WL	NULL
,	NULL
Weinstein-Oppenheimer	NULL
C	NULL
,	NULL
Chang	NULL
F	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Signal	NULL
transduction	NULL
,	NULL
cell	NULL
cycle	NULL
regulatory	NULL
,	NULL
and	NULL
anti-apoptotic	NULL
pathways	NULL
regulated	NULL
by	NULL
IL-3	NULL
in	NULL
hematopoietic	NULL
cells	NULL
:	NULL
possible	NULL
sites	NULL
for	NULL
intervention	NULL
with	NULL
anti-neoplastic	NULL
drugs	NULL
.	NULL

Leukemia	NULL
.	NULL

1999	NULL
;	NULL
13	NULL
:	NULL
1109-1166	NULL
.	NULL

6	NULL
.	NULL

Rollins	NULL
BJ	NULL
.	NULL

Chemokines	NULL
.	NULL

Blood	NULL
.	NULL

1997	NULL
;	NULL
90:909-928	NULL
.	NULL

7	NULL
.	NULL

Lefkowitz	NULL
PJ	NULL
.	NULL

G	NULL
protein-coupled	NULL
receptors	NULL
,	NULL
III	NULL
:	NULL
new	NULL
roles	NULL
for	NULL
receptor	NULL
kinase	NULL
and	NULL
B-arrestins	NULL
in	NULL
receptor	NULL
signaling	NULL
and	NULL
desensitization	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273:18677-18680	NULL
.	NULL

1999	NULL
;	NULL
104:220-229	NULL
.	NULL

3652-3658.	NULL
kine	NULL
receptor	NULL
CXCR4	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
megakaryocytic	NULL
lineage	NULL
from	NULL
progenitor	NULL
to	NULL
plate	NULL
lets	NULL
and	NULL
modulates	NULL
migration	NULL
and	NULL
adhesion	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
92:756-764	NULL
.	NULL

15	NULL
.	NULL

Kowalska	NULL
MA	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Hoxie	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Platelet	NULL
and	NULL
megakaryocytes	NULL
express	NULL
the	NULL
HIV	NULL
co-receptor	NULL
CXCR4	NULL
on	NULL
their	NULL
surface	NULL
but	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
stromal	NULL
derived	NULL
factor	NULL
(	NULL
SDF	NULL
)	NULL
-1	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

11	NULL
.	NULL

Riviere	NULL
C	NULL
,	NULL
Subara	NULL
F	NULL
,	NULL
Cohen-Solal	NULL
K	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Pheno-typic	NULL
and	NULL
functional	NULL
evidence	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
CXCR4	NULL
receptor	NULL
during	NULL
megakaryocytopoiesis	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:1511-1523	NULL
.	NULL

12	NULL
.	NULL

Aiuti	NULL
A	NULL
,	NULL
Webb	NULL
IJ	NULL
,	NULL
Bleul	NULL
C	NULL
,	NULL
Springer	NULL
T	NULL
,	NULL
Gutierrez-Ramos	NULL
JC	NULL
.	NULL

The	NULL
chemokine	NULL
SDF-1	NULL
is	NULL
a	NULL
chemoattractant	NULL
for	NULL
human	NULL
CD34+	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
and	NULL
provides	NULL
a	NULL
new	NULL
mechanism	NULL
to	NULL
explain	NULL
the	NULL
mobilization	NULL
of	NULL
CD34	NULL
+*	NULL
progenitors	NULL
to	NULL
peripheral	NULL
blood	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
185:111-120	NULL
.	NULL

18	NULL
.	NULL

13	NULL
.	NULL

Dutt	NULL
P	NULL
,	NULL
Wang	NULL
JF	NULL
,	NULL
Groopman	NULL
JE	NULL
.	NULL

Stromal	NULL
cell-derived	NULL
factor-1a	NULL
and	NULL
stem	NULL
cell	NULL
factor/kit	NULL
ligand	NULL
share	NULL
signaling	NULL
pathways	NULL
in	NULL
hemopoietic	NULL
progeni-tors	NULL
:	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
cooperative	NULL
induction	NULL
of	NULL
chemotaxis	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
161	NULL
:	NULL
19.	NULL
and	NULL
leukemic	NULL
cells	NULL
and	NULL
mediates	NULL
transendothelial	NULL
migration	NULL
induced	NULL
by	NULL
stromal	NULL
cell-derived	NULL
fac-tor-1	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
91:4523-4530	NULL
.	NULL

Naiyer	NULL
AJ	NULL
,	NULL
Jo	NULL
DY	NULL
,	NULL
Ahn	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Stromal	NULL
derived	NULL
factor-1	NULL
induced	NULL
chemokinesis	NULL
of	NULL
cord	NULL
blood	NULL
CD34	NULL
*	NULL
cells	NULL
(	NULL
long-term	NULL
culture-initiating	NULL
cells	NULL
)	NULL
through	NULL
endothelial	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
E-selec-tin	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:4011-4019	NULL
.	NULL

16	NULL
.	NULL

Hamada	NULL
T	NULL
,	NULL
Mohle	NULL
R	NULL
,	NULL
Hesselgesser	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Transendothelial	NULL
migration	NULL
of	NULL
megakaryocytes	NULL
in	NULL
response	NULL
to	NULL
stromal	NULL
cell-derived	NULL
factor-1	NULL
(	NULL
SDF-1	NULL
)	NULL
enhances	NULL
platelet	NULL
formation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1998	NULL
;	NULL
188:539-548	NULL
.	NULL

17	NULL
.	NULL

Hodohara	NULL
K	NULL
,	NULL
Fujii	NULL
N	NULL
,	NULL
Yamamoto	NULL
N	NULL
,	NULL
Kaushansky	NULL
K.	NULL
Stromal	NULL
cell-derived	NULL
factor-1	NULL
(	NULL
SDF-1	NULL
)	NULL
acts	NULL
together	NULL
with	NULL
thrombopoietin	NULL
to	NULL
enhance	NULL
the	NULL
development	NULL
of	NULL
megakaryocytic	NULL
progenitor	NULL
cells	NULL
(	NULL
CFU-MK	NULL
}	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:769-775	NULL
.	NULL

Ratajczak	NULL
MZ	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Machalanski	NULL
B	NULL
,	NULL
Mick	NULL
R	NULL
,	NULL
Gewirtz	NULL
AM	NULL
.	NULL

In	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
evidence	NULL
that	NULL
ex	NULL
vivo	NULL
cytokine	NULL
priming	NULL
of	NULL
donor	NULL
marrow	NULL
cells	NULL
may	NULL
ameliorate	NULL
post-transplant	NULL
thrombocytope-nia	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
91:353-359	NULL
.	NULL

Ratajczak	NULL
J	NULL
,	NULL
Machalinski	NULL
B	NULL
,	NULL
Samuel	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
novel	NULL
serum-free	NULL
system	NULL
for	NULL
cloning	NULL
human	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
15	NULL
DECEMBER	NULL
2000	NULL
»	NULL
VOLUME	NULL
96	NULL
,	NULL
NUMBER	NULL
13	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

286	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31.	NULL
megakaryocytic	NULL
progenitors	NULL
(	NULL
CFU-M	NULL
)	NULL
:	NULL
the	NULL
role	NULL
of	NULL
thrombopoietin	NULL
and	NULL
other	NULL
cytokines	NULL
on	NULL
bone	NULL
marrow	NULL
and	NULL
cord	NULL
blood	NULL
CFU-M	NULL
growth	NULL
under	NULL
serum	NULL
free	NULL
conditions	NULL
.	NULL

Folia	NULL
Histochem	NULL
Cytobiol	NULL
.	NULL

1998	NULL
;	NULL
36:55-60	NULL
.	NULL

Majka	NULL
M	NULL
,	NULL
Rozmyslowicz	NULL
T	NULL
,	NULL
Lee	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Bone	NULL
marrow	NULL
CD34*	NULL
cells	NULL
and	NULL
megakaryoblasts	NULL
secrete	NULL
B-chemokines	NULL
:	NULL
implications	NULL
for	NULL
infectability	NULL
by	NULL
M-tropic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
RS	NULL
HIV	NULL
}	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1999	NULL
;	NULL
104:1739-1749	NULL
.	NULL

Fichelson	NULL
S	NULL
,	NULL
Freyssinier	NULL
JM	NULL
,	NULL
Picard	NULL
F	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Megakaryocyte	NULL
growth	NULL
and	NULL
developmental	NULL
factor-induced	NULL
proliferation	NULL
and	NULL
differentiation	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
in	NULL
primitive	NULL
cord	NULL
blood	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:1601-1613	NULL
.	NULL

Faraday	NULL
N	NULL
,	NULL
Rade	NULL
JJ	NULL
,	NULL
Johns	NULL
DC	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Ex	NULL
vivo	NULL
cultured	NULL
megakaryocytes	NULL
express	NULL
functional	NULL
glycoprotein	NULL
Ilb-llla	NULL
receptors	NULL
and	NULL
are	NULL
capable	NULL
of	NULL
ad-enovirus-mediated	NULL
transgene	NULL
expression	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:4084-4092	NULL
.	NULL

Rojnuckarin	NULL
P	NULL
,	NULL
Drachman	NULL
JG	NULL
,	NULL
Kaushansky	NULL
K.	NULL
Thrombopoietin-induced	NULL
activation	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
pathway	NULL
in	NULL
normal	NULL
megakaryocytes	NULL
:	NULL
role	NULL
in	NULL
endomitosis	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:1273-1282	NULL
.	NULL

Drachman	NULL
JG	NULL
,	NULL
Millett	NULL
KM	NULL
,	NULL
Kaushansky	NULL
K.	NULL
Thrombopoietin	NULL
signal	NULL
transduction	NULL
requires	NULL
functional	NULL
JAK2	NULL
not	NULL
TYK2	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:13480-13484	NULL
.	NULL

Ganju	NULL
RK	NULL
,	NULL
Brubaker	NULL
SA	NULL
,	NULL
Meyer	NULL
J	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
B-chemoking	NULL
,	NULL
stromal	NULL
cell-derived	NULL
factor-1a	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
transmembrane	NULL
G-protein-coupled	NULL
CXCR-4	NULL
receptor	NULL
and	NULL
activates	NULL
multiple	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273	NULL
:	NULL
23169-23175	NULL
.	NULL

Banfic	NULL
H	NULL
,	NULL
Downes	NULL
CP	NULL
,	NULL
Rittenhouse	NULL
SE	NULL
.	NULL

Biphasic	NULL
activation	NULL
of	NULL
PKBa/AKT	NULL
in	NULL
platelets	NULL
:	NULL
evidence	NULL
for	NULL
stimulation	NULL
both	NULL
by	NULL
phosphatidylinositol	NULL
3,4-bi-phosphate	NULL
,	NULL
produced	NULL
via	NULL
a	NULL
novel	NULL
pathway	NULL
,	NULL
and	NULL
by	NULL
phosphatidylinositol	NULL
3,4,5-triphosphate	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
271:11630-11637	NULL
.	NULL

Liu	NULL
RY	NULL
,	NULL
Fan	NULL
C	NULL
,	NULL
Garcia	NULL
R	NULL
,	NULL
Jove	NULL
R	NULL
,	NULL
Zuckerman	NULL
KS	NULL
.	NULL

Constitutive	NULL
activation	NULL
of	NULL
JAK2/STATS	NULL
signal	NULL
transduction	NULL
pathway	NULL
correlates	NULL
with	NULL
growth	NULL
factor	NULL
independence	NULL
of	NULL
megakaryocytic	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:2369-2379	NULL
.	NULL

Miyakawa	NULL
Y	NULL
,	NULL
Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Thrombopoietin	NULL
and	NULL
thrombin	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
vav	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

Blood	NULL
.	NULL

1997	NULL
;	NULL
89:2789-2798	NULL
.	NULL

Miyakawa	NULL
Y	NULL
,	NULL
Oda	NULL
A	NULL
,	NULL
Druker	NULL
BJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Thrombopoietin	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat3	NULL
and	NULL
Stat5	NULL
in	NULL
human	NULL
blood	NULL
platelets	NULL
.	NULL

Blood	NULL
.	NULL

1996	NULL
;	NULL
87:439-446	NULL
.	NULL

Ratajczak	NULL
J	NULL
,	NULL
Zhang	NULL
Q	NULL
,	NULL
Pertusini	NULL
E	NULL
,	NULL
Wojczyk	NULL
B	NULL
,	NULL
Wasik	NULL
M	NULL
,	NULL
Ratajczak	NULL
MZ	NULL
.	NULL

The	NULL
role	NULL
of	NULL
insulin	NULL
(	NULL
INS	NULL
)	NULL
and	NULL
insulin	NULL
like	NULL
growth	NULL
factor-|	NULL
(	NULL
IGF-I	NULL
)	NULL
in	NULL
regulating	NULL
human	NULL
erythropoiesis	NULL
:	NULL
studies	NULL
in	NULL
vitro	NULL
under	NULL
serum	NULL
free	NULL
conditions-comparison	NULL
to	NULL
other	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

Leukemia	NULL
.	NULL

1998	NULL
;	NULL
12	NULL
:	NULL
371-381	NULL
.	NULL

Lee	NULL
B	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Doms	NULL
RW	NULL
,	NULL
Gewirtz	NULL
AM	NULL
,	NULL
Ratajczak	NULL
MZ	NULL
.	NULL

Coreceptor/chemokine	NULL
receptor	NULL
expression	NULL
on	NULL
human	NULL
hematopoietic	NULL
cells	NULL
:	NULL
biological	NULL
implications	NULL
for	NULL
HIV-1	NULL
infection	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:1145-1156	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Mariallo	NULL
A	NULL
,	NULL
Diaz	NULL
P	NULL
,	NULL
Blanco	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Properties	NULL
of	NULL
S-phase	NULL
tumor	NULL
cells	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
is	NULL
an	NULL
independent	NULL
prognostic	NULL
factor	NULL
in	NULL
meningi-oma	NULL
tumors	NULL
.	NULL

Cytometry	NULL
.	NULL

1999	NULL
;	NULL
38:118-123	NULL
.	NULL

Kim	NULL
NW	NULL
,	NULL
Wu	NULL
F.	NULL
Advances	NULL
in	NULL
quantitation	NULL
and	NULL
characterization	NULL
of	NULL
telomerase	NULL
activity	NULL
by	NULL
the	NULL
telomeric	NULL
repeat	NULL
amplification	NULL
protocol	NULL
(	NULL
TRAP	NULL
)	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

1997	NULL
;	NULL
25:2595-2597	NULL
.	NULL

Majka	NULL
M	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Lee	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
role	NULL
of	NULL
HIV-related	NULL
chemokine	NULL
receptors	NULL
and	NULL
chemokines	NULL
in	NULL
human	NULL
erythropoiesis	NULL
in	NULL
vitro	NULL
.	NULL

Stem	NULL
Cells	NULL
.	NULL

2000	NULL
;	NULL
18:128-138	NULL
.	NULL

Janiak	NULL
M	NULL
,	NULL
Hashmi	NULL
HR	NULL
,	NULL
Janowska-Wieczorek	NULL
A	NULL
.	NULL

Use	NULL
of	NULL
the	NULL
Matrigel-based	NULL
assay	NULL
to	NULL
measure	NULL
the	NULL
invasiveness	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

Exp	NULL
Hematol	NULL
.	NULL

1994	NULL
;	NULL
22:559-565	NULL
.	NULL

Janowska-Wieczorek	NULL
A	NULL
,	NULL
Marquez	NULL
LA	NULL
,	NULL
Nabholtz	NULL
J-M	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Growth	NULL
factors	NULL
and	NULL
cytokines	NULL
up-regu-late	NULL
gelatinase	NULL
expression	NULL
in	NULL
bone	NULL
marrow	NULL
CD34+*	NULL
cells	NULL
and	NULL
their	NULL
transmigration	NULL
through	NULL
reconstituted	NULL
basement	NULL
membrane	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
93:3379-3390	NULL
.	NULL

Janowska-Wieczorek	NULL
A	NULL
,	NULL
Marquez	NULL
LA	NULL
,	NULL
Matsuzaki	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Expression	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
(	NULL
MMP-2	NULL
and	NULL
-9	NULL
)	NULL
and	NULL
tissue	NULL
inhibitors	NULL
of	NULL
metalloproteinases	NULL
(	NULL
TIMP-1	NULL
and	NULL
-2	NULL
)	NULL
in	NULL
acute	NULL
myelog-enous	NULL
leukaemia	NULL
blasts	NULL
:	NULL
comparison	NULL
with	NULL
normal	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

1999	NULL
;	NULL
105:402-411	NULL
.	NULL

Shattil	NULL
SJ	NULL
,	NULL
Hoxie	NULL
JA	NULL
,	NULL
Cunningham	NULL
M	NULL
,	NULL
Brass	NULL
LF	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
platelet	NULL
membrane	NULL
glycoprotein	NULL
IIb/Illa	NULL
complex	NULL
during	NULL
platelet	NULL
activation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1985	NULL
;	NULL
260:11107-11114	NULL
.	NULL

Loh	NULL
E	NULL
,	NULL
Beaverson	NULL
K	NULL
,	NULL
Vilaire	NULL
G	NULL
,	NULL
Qi	NULL
W	NULL
,	NULL
Poncz	NULL
M	NULL
,	NULL
Bennett	NULL
JS	NULL
.	NULL

Agonist-stimulated	NULL
ligand	NULL
binding	NULL
by	NULL
the	NULL
platelet	NULL
integrin	NULL
cells	NULL
in	NULL
a	NULL
lymphocyte	NULL
expression	NULL
system	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1995	NULL
;	NULL
270	NULL
:	NULL
18631-18636	NULL
.	NULL

Bellavite	NULL
P	NULL
,	NULL
Andrioli	NULL
G	NULL
,	NULL
Guzzo	NULL
P	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
colorimetric	NULL
method	NULL
for	NULL
the	NULL
measurements	NULL
of	NULL
platelet	NULL
adhesion	NULL
in	NULL
microtiter	NULL
plates	NULL
.	NULL

Anal	NULL
Biochem	NULL
.	NULL

1994	NULL
;	NULL
216:444-450	NULL
.	NULL

Pan	NULL
ZK	NULL
,	NULL
Christiansen	NULL
SC	NULL
,	NULL
Ptasznik	NULL
A	NULL
,	NULL
Zuraw	NULL
BL	NULL
.	NULL

Requirement	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
activity	NULL
for	NULL
bradykinin	NULL
stimulation	NULL
of	NULL
NF-	NULL
«	NULL
b	NULL
activation	NULL
in	NULL
cultured	NULL
human	NULL
epithelial	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:9918-9922	NULL
.	NULL

Ghosh	NULL
S	NULL
,	NULL
May	NULL
MJ	NULL
,	NULL
Kopp	NULL
EB	NULL
.	NULL

NF-kB	NULL
and	NULL
rel	NULL
pro-teins	NULL
:	NULL
evolutionarily	NULL
conserved	NULL
mediators	NULL
of	NULL
immune	NULL
response	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
16	NULL
:	NULL
225-260	NULL
.	NULL

Lataillade	NULL
J-J	NULL
,	NULL
Clay	NULL
D	NULL
,	NULL
Dupuy	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Chemokine	NULL
SDF-1	NULL
enhances	NULL
circulating	NULL
CD34	NULL
+	NULL
cell	NULL
proliferation	NULL
in	NULL
synergy	NULL
with	NULL
cytokines	NULL
:	NULL
possible	NULL
role	NULL
in	NULL
progenitor	NULL
survival	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:756-768	NULL
.	NULL

Ratajczak	NULL
MZ	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Marlicz	NULL
W	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Recombinant	NULL
human	NULL
thrombopoietin	NULL
(	NULL
Tpo	NULL
)	NULL
stimulates	NULL
erythropoiesis	NULL
by	NULL
inhibiting	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
apoptosis	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

1997	NULL
;	NULL
98	NULL
:	NULL
8-17	NULL
.	NULL

Broudy	NULL
VC	NULL
,	NULL
Kaushansky	NULL
K.	NULL
Biology	NULL
of	NULL
thrombopoietin	NULL
.	NULL

Curr	NULL
Opin	NULL
Pediatr	NULL
.	NULL

1998	NULL
;	NULL
10:60-64.	NULL
van	NULL
Engeland	NULL
M	NULL
,	NULL
Nielwand	NULL
LJ	NULL
,	NULL
Ramaekens	NULL
FC	NULL
,	NULL
Schutte	NULL
B	NULL
,	NULL
Reutelingsperger	NULL
A.	NULL
Annexin	NULL
V	NULL
affinity	NULL
assay	NULL
:	NULL
a	NULL
review	NULL
on	NULL
an	NULL
apoptosis	NULL
detection	NULL
system	NULL
based	NULL
on	NULL
phosphatidylserine	NULL
exposure	NULL
.	NULL

Cytometry	NULL
.	NULL

1998	NULL
;	NULL
31:1-9	NULL
.	NULL

SDF-1	NULL
AND	NULL
TPO	NULL
IN	NULL
MEGAKARYOPOIESIS	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

4151	NULL
Datta	NULL
SR	NULL
,	NULL
Dudek	NULL
H	NULL
,	NULL
Tao	NULL
X	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Akt	NULL
phosphorylation	NULL
of	NULL
BAD	NULL
couples	NULL
survival	NULL
signals	NULL
to	NULL
the	NULL
cell	NULL
intrinsic	NULL
death	NULL
machinery	NULL
.	NULL

Cell	NULL
.	NULL

1997	NULL
;	NULL
91:231-241	NULL
.	NULL

Songyang	NULL
Z	NULL
,	NULL
Baltimore	NULL
D	NULL
,	NULL
Cantley	NULL
LC	NULL
,	NULL
Kaplan	NULL
DR	NULL
,	NULL
Franke	NULL
TF	NULL
.	NULL

Interleukin-3	NULL
dependent	NULL
survival	NULL
by	NULL
the	NULL
Akt	NULL
protein	NULL
kinase	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
SA	NULL
.	NULL

1997	NULL
;	NULL
94:11345-11350	NULL
.	NULL

Khwaja	NULL
A.	NULL
Akt	NULL
is	NULL
more	NULL
than	NULL
just	NULL
Bad	NULL
kinase	NULL
.	NULL

Sci-ence	NULL
.	NULL

1999	NULL
;	NULL
401:33-34	NULL
.	NULL

Kelly	NULL
TW	NULL
,	NULL
Graham	NULL
MM	NULL
,	NULL
Doseff	NULL
Al	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Macro-phage	NULL
colony	NULL
stimulating	NULL
factor	NULL
promotes	NULL
cell	NULL
survival	NULL
through	NULL
Akt/protein	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:26393-26398	NULL
.	NULL

Kojima	NULL
H	NULL
,	NULL
Hamazaki	NULL
Y	NULL
,	NULL
Nagata	NULL
Y	NULL
,	NULL
Todokoro	NULL
K	NULL
,	NULL
Nagasawa	NULL
T	NULL
,	NULL
Abe	NULL
T.	NULL
Modulation	NULL
of	NULL
platelet	NULL
activation	NULL
in	NULL
vitro	NULL
by	NULL
thrombopoietin	NULL
.	NULL

Thromb	NULL
Haemost	NULL
.	NULL

1995	NULL
;	NULL
74:1541-1545	NULL
.	NULL

Wang	NULL
J-F	NULL
,	NULL
Park	NULL
I-W	NULL
,	NULL
Groopman	NULL
JE	NULL
.	NULL

Stromal	NULL
cell-derived	NULL
factor-1	NULL
«	NULL
stimulates	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
focal	NULL
adhesion	NULL
proteins	NULL
and	NULL
induces	NULL
migration	NULL
of	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
:	NULL
roles	NULL
of	NULL
phosphoinositide-3	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Blood	NULL
.	NULL

2000	NULL
;	NULL
95:2505-2513	NULL
.	NULL

Kowalska	NULL
MA	NULL
,	NULL
Ratajczak	NULL
MZ	NULL
,	NULL
Majka	NULL
M	NULL
,	NULL
Brass	NULL
LW	NULL
,	NULL
Ponez	NULL
M.	NULL
SDF-1	NULL
and	NULL
MDC	NULL
:	NULL
complementary	NULL
chemokines	NULL
at	NULL
the	NULL
crossroads	NULL
between	NULL
inflammation	NULL
and	NULL
thrombosis	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
96:50-57	NULL
.	NULL

Gutkind	NULL
JS	NULL
.	NULL

The	NULL
pathways	NULL
connecting	NULL
G	NULL
protein-coupled	NULL
receptors	NULL
to	NULL
the	NULL
nucleus	NULL
through	NULL
divergent	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascades	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1998	NULL
;	NULL
273:1839-1842	NULL
.	NULL

Mohle	NULL
R	NULL
,	NULL
Green	NULL
D	NULL
,	NULL
Moore	NULL
MAS	NULL
,	NULL
Nachman	NULL
RL	NULL
,	NULL
Rafii	NULL
S.	NULL
Constitutive	NULL
production	NULL
and	NULL
thrombin-induced	NULL
release	NULL
of	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
by	NULL
hurnan	NULL
megakaryocytes	NULL
and	NULL
platelets	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1997	NULL
;	NULL
94	NULL
;	NULL
663-668	NULL
.	NULL

Ratajczak	NULL
MZ	NULL
,	NULL
Ratajczak	NULL
J	NULL
,	NULL
Machalinski	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Role	NULL
of	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
(	NULL
VEGF	NULL
)	NULL
and	NULL
placenta-derived	NULL
growth	NULL
factor	NULL
(	NULL
PIGF	NULL
)	NULL
in	NULL
regulating	NULL
human	NULL
haematopoietic	NULL
growth	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
.	NULL

1998	NULL
;	NULL
103:969-979	NULL
.	NULL

Peled	NULL
A	NULL
,	NULL
Grabovsky	NULL
V	NULL
,	NULL
Habler	NULL
L	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
chemokine	NULL
SDF-1	NULL
stimulates	NULL
integrin-mediated	NULL
arrest	NULL
of	NULL
CD34+	NULL
cells	NULL
on	NULL
vascular	NULL
endothelium	NULL
under	NULL
shear	NULL
flow	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

1999	NULL
;	NULL
104:1199-1211	NULL
.	NULL

Hinton	NULL
HJ	NULL
,	NULL
Welham	NULL
MJ	NULL
.	NULL

Cytoking-induced	NULL
protein	NULL
kinase	NULL
B	NULL
activation	NULL
and	NULL
Bad	NULL
phosphorylation	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
cell	NULL
survival	NULL
of	NULL
hemopoietic	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
162:7002-7009	NULL
.	NULL

Bond	NULL
M	NULL
,	NULL
Fabunmi	NULL
RP	NULL
,	NULL
Baker	NULL
AH	NULL
,	NULL
Newby	NULL
AC	NULL
.	NULL

Synergistic	NULL
up-regulation	NULL
of	NULL
metalloproteinase-9	NULL
by	NULL
growth	NULL
factors	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
:	NULL
an	NULL
absolute	NULL
requirement	NULL
for	NULL
transcriptional	NULL
factor	NULL
NF-kappa	NULL
B.	NULL
FEBS	NULL
Lett	NULL
.	NULL

1998	NULL
;	NULL
435:29-34	NULL
.	NULL

Yoshida	NULL
S	NULL
,	NULL
Ono	NULL
M	NULL
,	NULL
Shono	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Involvement	NULL
of	NULL
interleukin-8	NULL
,	NULL
vascular	NULL
endothelial	NULL
growth	NULL
factor	NULL
,	NULL
and	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha-dependent	NULL
angiogenesis	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1997	NULL
;	NULL
17:4015-4023	NULL
.	NULL

Lim	NULL
CP	NULL
,	NULL
Cao	NULL
X.	NULL
Serine	NULL
phosphorylation	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
STAT3	NULL
by	NULL
JNK	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1999	NULL
;	NULL
274:31055-31061	NULL
.	NULL

Dohlman	NULL
HG	NULL
,	NULL
Thorner	NULL
J.	NULL
RGS	NULL
proteins	NULL
and	NULL
signaling	NULL
by	NULL
heterotrimeric	NULL
G	NULL
proteins	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1997	NULL
;	NULL
272:3871-3874	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
2000	NULL
96	NULL
:	NULL
4142-4151	NULL
Stromal-derived	NULL
factor	NULL
1	NULL
and	NULL
thrombopoietin	NULL
regulate	NULL
distinct	NULL
aspects	NULL
of	NULL
human	NULL
megakaryopoiesis	NULL
4	NULL
73g	NULL
“	NULL
Pay	NULL
A	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
``	NULL
Ctown®	NULL
@	NULL
``	NULL
20	NULL
Marcin	NULL
Majka	NULL
,	NULL
Anna	NULL
Janowska-Wieczorek	NULL
,	NULL
Janina	NULL
Ratajczak	NULL
,	NULL
M.	NULL
Anna	NULL
Kowalska	NULL
,	NULL
Gaston	NULL
Vilaire	NULL
,	NULL
Zhixing	NULL
K.	NULL
Pan	NULL
,	NULL
Marek	NULL
Honczarenko	NULL
,	NULL
Leah	NULL
A.	NULL
Marquez	NULL
,	NULL
Mortimer	NULL
Poncz	NULL
and	NULL
Mariusz	NULL
Z.	NULL
Ratajczak	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/96/13/4142.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Chemokines	NULL
,	NULL
Cytokines	NULL
,	NULL
and	NULL
Interleukins	NULL
(	NULL
564	NULL
articles	NULL
)	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

